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ABSTRACT 
 
Apoptosis is a process whereby the unwanted cells are removed 
by a specific program. Currently, two main apoptotic pathways 
are known: mitochondrial and death receptor pathway. Bcl-2 
family proteins regulate the critical decision step in the 
mitochondrial pathway of apoptotic death, controlling the release 
of cytochrome c from the mitochondria to the cytosol. Release of 
cytochrome c leads to the activation of caspases, the proteases 
that execute the apoptotic death. Mitochondrial death pathway is 
also activated in the cultured sympathetic neurons deprived of 
nerve growth factor (NGF), a model for programmed neuronal 
death. This thesis investigates the expression and role of the 
splice variants of pro-apoptotic Bcl-2 family protein Bak in the 
cultured sympathetic neurons. We described and characterized 
N-Bak, a novel BH3-only splice variant of Bak. N-Bak mRNA is 
expressed neuron-specifically and its expression begins 
concomitantly with the beginning of neurogenesis in the early 
mouse embryo. Alternative splicing completely replaces Bak 
mRNA with N-Bak mRNA in the (at least cultured sympathetic 
and hippocampal) neurons. Absence of Bak in the sympathetic 
neurons was confirmed at the protein level. N-Bak was anti-
apoptotic when overexpressed in the NGF-deprived sympathetic 
neurons, whereas it was pro-apoptotic in non-neuronal cells. 
Mutational analysis revealed that this neuronal protection was 
only partially dependent of its BH3 domain and C-terminal 
transmembrane domain. Artificial BH3-only version of Bax, 
another pro-apoptotic Bcl-2 family protein (a structural analogue 
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of N-Bak) was also neuroprotective, when overexpressed in the 
sympathetic neurons. Overexpressed N-Bak did not prevent but 
even actively induced the release of cytochrome c from the 
mitochondria to the cytosol. However, the activation of caspases 
seems to be blocked in N-Bak-overexpressing neurons as 
suggested by the lack of cleavage of the fluorophore substrate 
containing caspase-3 cleavage site, and the lack of condensed 
apoptotic chromatin (the process that requires activated 
caspase-3) in the electron micrographs. Thus overexpressed N-
Bak protects NGF-deprived sympathetic neurons from apoptosis 
by preventing activation of caspases. Endogeneous N-Bak 
protein remains undetectable in the neurons. Probably the 
mRNA of N-Bak is not constitutively translated. Putative 
situations of N-Bak mRNA translation remain unknown. 
Consequently, it is currently unknown whether and how the anti-
apoptotic properties of N-Bak are used in the sympathetic 
neurons in vivo. Bad-β, a BH3-only splice variant of another Bcl-
2 family member Bad, appeared functionally indistinguishable 
from the main isoform Bad-α. In summary, our study suggests 
that the regulation of apoptosis by Bcl-2 family proteins in the 
neurons is considerably different from that described for the non-
neuronal cells. 
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1. REVIEW OF LITERATURE 
 
1.1. Introduction 
 
Programmed cell death, a process whereby the cells die in a 
`predicted or programmed’ way during normal development, was 
recognized more than 150 years ago (Glucksmann, 1965). In 
1972, Kerr et al. coined the term “apoptosis” to describe a most 
encountered form of PCD (Kerr et al., 1972). Until the late 
1980's, study of PCD focused on the morphological 
characterization of cell death. It is only last two decades that 
apoptosis has attracted extensive research interest mainly due 
to the establishment of molecular pathways of apoptosis and the 
identification of several key apoptosis regulators in 
Caenorhabditis elegans and subsequently their counterparts in 
mammals (Conradt and Horvitz, 1998; Hengartner and Horvitz, 
1994a; Yuan and Horvitz, 1992; Yuan et al., 1993). The large 
interest in apoptosis is also promoted by the realization that 
apoptosis is as an important fundamental cellular process as 
proliferation and differentiation, and by the finding that apoptosis 
is critically involved in a wide range of pathophysiological 
conditions (Thompson, 1995). Apoptosis is the most 
encountered and best characterized form of PCD. In this review, 
these terms will be used as synonyms, while non-apoptotic 
forms of cell death will be specified whenever encountered.   
Now it is generally accepted that apoptosis is an 
evolutionarily conserved cellular process and plays a pivotal role 
in the development and throughout the whole lifespan of an 
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organism (Vaux, 1992; Vaux and Korsmeyer, 1999; Ameisen, 
2002). It is essential in sculpting the shape of the developing 
organs and keeping appropriate cell number by removing 
unwanted or superfluous cells excessively produced during 
development. Apoptosis is necessary to eliminate the damaged 
or infected cells and to ensure tissue homeostasis by mediating 
the turnover of the cells. Apoptosis is implicated in a number of 
human and animal disorders including infectious diseases, 
ischemia, stroke, heart diseases, neurodegenerative diseases, 
tumorigenesis and autoimmunity (Thompson, 1995). Better 
understanding of the molecular mechanisms regulating 
apoptosis is of great importance for the prevention or treatment 
of these disorders. Therefore, apoptosis is becoming a major 
biomedical and biotechnological issue as illustrated by 
publication statistics: of the total number of papers on apoptosis 
published over the past 30 years, 25% appeared in 2000 (13 040 
publications in 2000, 11017 in 2001 and 10850 in 2002).  
Current understanding of molecular pathways regulating 
apoptosis in mammalian cell is largely derived from the studies 
of programmed cell death in the nematode Caenorhabditis 
elegans. In C elegans, developmental cell death is controlled by 
a simple genetic pathway, involving the sequential and 
coordinated actions of EGL-1, CED-9, CED-4, and CED-3 
(Horvitz et al., 1994; Hengartner and Horvitz, 1994b). Apoptosis 
in vertebrates has turned out to be more complex, as numerous 
related genes serve a distinct but still partially redundant 
function. It is generally accepted that mammalian cells have 
evolved multiple redundant and complementary death pathways. 
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Therefore, cellular response to death stimuli and the type of cell 
death are highly cell- or tissue-type dependent. Several still 
growing families of proteins have been critically implicated in 
regulating apoptosis. Among them, death receptors and their 
ligands (Nagata, 1997; Ashkenazi and Dixit, 1999), Bcl-2 family 
proteins (Adams and Cory, 2001; Bouillet and Strasser, 2002; 
Korsmeyer, 1999), caspases (Li and Yuan, 1999; Earnshaw et 
al., 1999; Denault and Salvesen, 2002) as well as other 
proteases such as cathepsins (Katunuma et al., 2001; Deiss et 
al., 1996; Kagedal et al., 2001) and serine proteases (Darmon et 
al., 1995; Quan et al., 1996; Martin et al., 1996; Yang et al., 
1998; Suzuki et al., 2001; Verhagen et al., 2002a), but also 
inhibitors of apoptosis proteins (Hawkins et al., 1998; Verhagen 
et al., 2001; Salvesen and Duckett, 2002), are under extensive 
study. By regulating mitochondrial function and release of a 
number of apoptogenic factors, Bcl-2 family proteins function at 
the main checkpoint of apoptosis. Most death signaling 
pathways culminate in the activation of caspases, which in turn 
execute the death by cleaving key cellular substrates essential 
for cellular structure and/or homeostatic pathways. Based on the 
mode of caspase activation, apoptotic pathways can broadly be 
divided into two major death pathways: extrinsic (or death 
receptor) pathway and intrinsic (or mitochondrial) pathway.  
 
1.2. Classification of cell death: apoptosis and necrosis  
 
Depending on the cell types, developmental stages, metabolic 
states and death stimuli, the cells can die by programmed or 
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nonprogrammed way or the way with mixed morphological 
features. Apoptosis is a major form of programmed cell death, 
although there are still other types of programmed cell death, 
especially in pathological situations (autophagic death, 
cytoplasmic death, parapoptosis etc.). These modes of cell 
death are, however, much less studied (Schweichel and Merker, 
1973; Majno and Joris, 1995; Clarke, 1990; Forcet et al., 2001; 
Castro-Obregon et al., 2002; Sperandio et al., 2000). 
Apoptosis and necrosis are distinguished by a number of 
morphological and biochemical features. Apoptosis accounts for 
most of physiological cell death, whereas necrosis is usually 
induced in pathological situation by accidental and acute 
damage to cells. Apoptosis is characterized by several distinct 
morphological and biochemical features including membrane 
blebbing, pyknotic shrinkage of the cell body, chromatin 
condensation, internuclearsomal DNA fragmentation (Williams et 
al., 1974) and formation of apoptotic bodies that are engulfed 
rapidly by macrophages or neighboring cells, thus preventing 
inflammatory response (Figure 1) (Wyllie et al., 1980; Fiers et al., 
1999).  
During earlier phase of apoptosis, cellular organelles 
remain relatively intact (Kerr et al., 1995). In addition, activation 
of caspases and exposure of phosphatidylserine on the cell 
surface are the characteristics of apoptosis (Raynal and Pollard, 
1994; Martin et al., 1995). In contrast, necrosis often involves 
total depletion of cellular energy, cell swelling, extensive 
membrane and intracellular organelle disruption and release of 
the cellular contents into the surrounding tissue, eliciting a 
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massive inflammatory response (Alison and Sarraf, 1994). 
However, these two forms of cell death are distinct but parts of  
 
 
 
Figure 1. Morphological changes in the apoptosis and necrosis. A 
cell can die either apoptotically (right) or necrotically (left). Apoptotic 
death includes:  I. Shrinkage of the cell, condensation and margination 
of the chromatin whereas the organelles remain mainly unchanged. II. 
Fragmentation of the cell into apoptotic bodies with intact plasma 
membrane and mainly normal organelles. III. Engulfment of the 
apoptotic bodies by neighbouring phagocytic cells. Necrotic death 
includes: I. Swelling of the cell and the organelles, diffuse partial 
condensation of the chromatin. II. Breakage of the plasma membrane, 
Healthy cell
Apoptosis
Necrosis
Phagocyte
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spillage of the cellular contents to the surrounding tissue, breakage of 
the organelles. Modified from kerr (Kerr et al., 1995).  
 
 
the continuum of cell death and there are many examples where 
the features of both death types are found in the same cell to 
various extents. It is believed that at least some aspects of 
necrosis may be programmed although perhaps to a lesser 
extend. Recent studies have demonstrated that intracellular ATP 
level and Ca2+ homeostasis are the key determinants regulating 
the mode of cell death (Xu et al., 2001; Schwab et al., 2002; 
Leist et al., 1997; Crompton, 1999; Proskuryakov et al., 2003).  
 
1.3. Apoptotic pathways 
 
Based on the mode of caspase activation, apoptosis can be 
catalogued to two major pathways: extrinsic or death receptor 
pathway and intrinsic or mitochondrial pathway. Both pathways 
culminate in the activation of caspases, which cleave key cellular 
substrates, leading to the morphological features of apoptosis 
(Vander Heiden et al., 2001).  
 
1.3.1. Intrinsic or mitochondrial apoptotic pathway  
All cells possess intrinsic death machinery, which is in healthy 
cells kept under strict control. Cellular stress or loss of survival 
signals releases the death machinery and triggers apoptosis via 
mitochondrial pathway (Desagher and Martinou, 2000; Ferri and 
Kroemer, 2001a; Kroemer and Reed, 2000). Mitochondrion plays 
 17 
a central role in apoptosis by sequestering in its intermembrane 
space a number of apoptogenic factors, including cytochrome c, 
AIF (apoptosis inducing factor) (Susin et al., 1999), 
Smac/DIABLO (Du et al., 2000; Verhagen et al., 2000), 
Endonuclease G (Li et al., 2001) and serine protease Omi/HtrA 
(Suzuki et al., 2001; Hegde et al., 2002). Bcl-2 family proteins 
critically regulate apoptotic function of the mitochondria. 
Following death stimulus, pro-apoptotic Bcl-2 proteins are 
activated and translocated to mitochondria, where they induce 
mitochondrial membrane permeabilization and release of several 
apoptogenic factors into the cytosol. Once released, cytochrome 
c binds to Apaf-1 (apoptotic protease activating factor-1) (Zou et 
al., 1997) in the presence of ATP/dATP and induces the 
assembly of apoptosome (a complex of cytochrome c, dATP, 
Apaf-1 and pro-caspase-9), upon which caspase-9 is activated 
(Liu et al., 1996). Activated caspase-9 in turn activates effector 
caspases such as caspase-3, -6, and –7, leading to final 
demolition of the cell (Slee et al., 1999). On the other hand, 
Smac/DIABLO and Omi/HtrA antagonize the activity of inhibitor 
of apoptosis proteins (IAPs) to ensure the full activation of 
caspases (Slee et al., 1999; Verhagen et al., 2000; Verhagen 
and Vaux, 2002; Verhagen et al., 2002b; Verhagen and Vaux, 
2002; Wu et al., 2000; Liu et al., 2000; Chai et al., 2000). 
 
1.3.2. Extrinsic apoptotic pathway or death receptor 
pathway 
Mammals have evolved an instructive, non-autonomous mode of 
cell death that enables the organism actively to direct individual 
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cells to undergo cell death. This directed cell death occurs 
through ligation and activation of the plasma membrane death 
receptors on target cells and is especially important in the 
immune system (Krammer, 2000). Death receptors belong to the 
tumor necrosis factor (TNF) (Ameyar-Zazoua et al., 2002) 
receptor gene superfamily. Of the best characterized are CD95 
(also called Apo 1 or Fas) and TNFR-1, each of which contains 
an extracellular cysteine-rich domain and an intracellular death 
domain that is essential for interacting and recruiting adaptor 
molecule and transducing death signal.  Death ligands, the 
members of TNF superfamily, are presented as trimers on the 
surface of killer cells or the vesicles derived from the killer cells 
(Klaus et al., 1998; Ashkenazi and Dixit, 1999; Nagata, 1997). 
Binding of CD95/Fas by FasL causes the aggregation of the 
death receptors and recruitment of a cytoplasmic adapter FADD 
(Vincenz and Dixit, 1997), followed by formation of a death-
inducing signaling complex (DISC) (Kischkel et al., 1995; 
Chinnaiyan et al., 1996; Papoff et al., 1999; Chan et al., 2000; 
Medema et al., 1997; Walczak and Sprick, 2001). Pro-caspase-8 
or –10 is recruited DISC by binding to FADD via their death 
effector domains (DEDs) and then activated by induced-
proximity manner (Muzio et al., 1996; Wang et al., 2001; Vincenz 
and Dixit, 1997; Fernandes-Alnemri et al., 1996). Activated 
caspase-8/10 can initiate the activation of caspase cascade by 
direct cleavage of effector caspases such caspase-3, -6, and -7 
(type 1 cells). TNFR-1 also activates caspases 8/10 through 
FADD, but TNFR-1 requires TRADD (TNFR1 associated death 
domain protein) to act as an adaptor between the receptor and 
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FADD (Hsu et al., 1995). Unlike CD95/Fas, TNF induced 
apoptosis needs concomitant inhibition of protein synthesis 
(Wong and Goeddel, 1994; Natoli et al., 1998; Plumpe et al., 
2000; Van Antwerp et al., 1996). In some cases, the activity of 
caspase-8 is so low that the death signal must be amplified by 
mitochondrial pathway (type 2 cells). In these cells, caspase-8 
cleaves p22 Bid into p15 tBid, which then binds to and activates 
Bax and/or Bak, induces mitochondrial permeabilization and 
subsequent cell death (Scaffidi et al., 1998; Scaffidi et al., 1999; 
Li et al., 1998; Luo et al., 1998). 
 
1.4. Bcl-2 family  
 
Bcl-2 family proteins function at the major checkpoint where cells 
make their decision to die or to live (Gross et al., 1999; Cory and 
Adams, 2002; Cory and Adams, 2002). As shown in (Figure 2), 
Bcl-2 family proteins share sequence conservation in one to four 
Bcl-2 homology (BH) domains. They can be divided into anti- 
and pro-apoptotic members. Anti-apoptotic members such as 
Bcl-2 (Hockenbery et al., 1990), Bcl-xL (Boise et al., 1993; 
Hockenbery et al., 1990), Bcl-w (Gibson et al., 1996), Mcl-1 
(Zhou et al., 1997) and A1/Bfl-1 (Lin et al., 1993) have all four 
BH-domains (BH1-4). Pro-apoptotic proteins can be further 
subdivided into two subgroups: the multidomain members 
including Bax (Oltvai et al., 1993), Bak (Chittenden et al., 1995) 
and Bok/Mtd (Hsu et al., 1997a) contain three BH domains 
(BH1-3) and BH3-only proteins possess only the BH3-domain 
that is essential for the interaction with other Bcl-2 proteins 
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(Bouillet and Strasser, 2002). BH3-only members, including Bid 
(Wang et al., 1996), Bim (O'Connor et al., 1998), Bad (Yang et 
al., 1995), DP5/Hrk (Inohara et al., 1997; Imaizumi et al., 1997), 
Bcl-xS  (Minn et al., 1996), Blk (Hegde et al., 1998), Bik (Boyd et 
al., 1995),  
 
Figure 2. Proteins of the Bcl-2 family. Shown are the main functional 
domains: BH1, BH2, BH3, BH4 and transmembrane (™) domains. The 
proteins are functionally grouped as anti-apoptotic (mostly BH1-4 
proteins), pro-apoptotic BH1-3 proteins, pro-apoptotic BH3-only 
Bad-α
Bid
A1
Bcl-GL
Hrk/DP5
Noxa
Rad9
BH4 BH3 BH1 BH2
Anti-apoptotic (BH1-4)
Pro-apoptotic (BH1-3)
Pro-apoptotic (BH3-only)
Exceptional
TM
Mcl-1S
Bcl-GS
Bcl-xL
Bcl-rambo
Bcl-xS
Bcl-2-α
Bcl-w
Mcl-1L
DIVA/Boo
Bax-α
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N-Bak
Mtd
BimEL
Bik
Blk
(BH3-only)
(BH3-only)
(BH3-only)
(BH3-only)
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proteins and the proteins with exceptional modular structure. BH3-only 
alternatively spliced isoforms of multi-BH-domain proteins (Bcl-xS, Mcl-
1S, N-Bak and Bcl-GS) are also shown. To facilitate the comparison of 
the splice isoforms, the BH3-only versions are shown together with 
longer versions, not in the BH3-only group. The underlined region is 
the sequence changed by the alternative splicing. For other Bcl-2 
family proteins, only the main isoforms are shown, as the composition 
of BH domains is not changed in the other isoforms.  
 
 
 
Bnip3, Nix, Mcl-1S (Bae et al., 2000; Bingle et al., 2000), Bcl-GS 
(Guo et al., 2001), Noxa (Oda et al., 2000) and Puma (Nakano 
and Vousden, 2001; Yu et al., 2001), function as important 
upstream death initiators regulating the activities of multi-domain 
Bcl-2 members. Most of Bcl-2 proteins harbour also a carboxyl-
terminal transmembrane domain, targeting them to intracellular 
membranes, predominantly to mitochondria, but also to 
endoplasmic reticulum (ER) and nuclear envelope (Hsu et al., 
1997b; Lithgow et al., 1994; Nutt et al., 2002; O'Reilly et al., 
2001; Scorrano et al., 2003).  
Three-dimensional structures of Bcl-2 (Petros et al., 
2001), Bcl-xL (Aritomi et al., 1997; Muchmore et al., 1996), Bcl-w 
(Hinds et al., 2003; Denisov et al., 2003) and Bax (Suzuki et al., 
2000) show striking similarity, suggesting that the basic blueprint 
of all multi-BH-domain proteins is similar with only minor 
variations, which still make some proteins anti-apoptotic and 
others pro-apoptotic. All these proteins comprise two central 
hydrophobic α-helices (Brunner et al., 1996) surrounded by five 
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amphipathic helices (Glicksman et al., 1998). BH1, BH2, and 
BH3 regions form an elongated hydrophobic cleft on the surface 
of the protein (Fesik, 2000). This cleft can act as a receptor 
pocket for the BH3 domain of another Bcl-2 family protein, as 
directly demonstrated by the binding of the BH3-peptides to 
hydrophobic clefts of Bcl-xL and Bcl-w. These interactions are 
critical for the activation/inactivation of the anti-apoptotic Bcl-2 
proteins. The hydrophobic clefts of at least Bax and Bcl-w are 
normally occupied with their C-terminal regions, thus 
conformation change to remove the C-terminal region from the 
hydrophobic cleft is required for the interaction of the cleft with 
BH3 domain, but also for the insertion of the C-terminal region 
into mitochondrial membrane. Consistent with current prevailing 
model, synthetic BH3 peptides from Bak, Bax, Bid, Bad and Blk 
can replace C-terminal region of Bcl-w and interact with the 
hydrophobic cleft (Denisov et al., 2003). An unstructured flexible 
loop between BH4 and BH3 domains harbours several 
phosphorylation sites and putative caspase cleavage site and 
serves as a negative regulatory region (Blagosklonny, 2001; 
Chang et al., 1997; Srivastava et al., 1999; Yamamoto et al., 
1999). NMR structure of a BH3-only protein Bid was found to be 
surprisingly similar to that of its multi-domain relatives, despite 
the lack of sequence homology (Chou et al., 1999; McDonnell et 
al., 1999). The crystal structure of the Bcl-2 family proteins 
showed significant similarity to pore-forming domains of bacterial 
toxins such as colicins and diphtheria toxin, suggesting a pore-
forming property of these proteins. The region spanning BH1 
and BH2 domain (Brunner et al., 1996) was predicted to form the 
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channel (Muchmore et al., 1996; Petros et al., 2001). It has 
shown that Bcl-2, Bcl-xL and Bax can form ion-conducting 
channels to synthetic lipid vesicles and planar lipid bilayers 
(Minn et al., 1997; Schendel et al., 1998; Antonsson et al., 1997; 
Schlesinger et al., 1997; Roucou et al., 2002b).  
The mechanisms how Bcl-2 family proteins regulate 
apoptosis are under extensive study but still poorly understood. 
The regulations involve complex interactions between pro- and 
anti-apoptotic members, as well as diverse modifications that 
change the conformation and intracellular localization of pro-
apoptotic proteins (Adams and Cory, 2001; Bouillet and 
Strasser, 2002; Korsmeyer, 1999). Anti-apoptotic Bcl-2 proteins 
associate with the mitochondrial outer membrane, ER or nuclear 
membrane and maintain their integrity (Krajewski et al., 1993; 
Hsu et al., 1997b; Krajewski et al., 1993; Lithgow et al., 1994; 
Nutt et al., 2002; O'Reilly et al., 2001; Scorrano et al., 2003). 
Either Bax or Bak is necessary for the dysfunction of 
mitochondria or ER and release of apoptogenic factors (Wei et 
al., 2001; Lindsten et al., 2000; Zong et al., 2001). Initiation of 
apoptosis also requires BH3-only proteins (Huang and Strasser, 
2000). Thus, in healthy cells, pro-apoptotic members are 
transcriptionally suppressed or sequestered to distinct 
subcellular compartments and kept inactive by diverse post-
translational mechanisms that are released by apoptotic stimulus 
(Puthalakath and Strasser, 2002). E.g. Bax is kept in the cytosol 
of healthy cells as inactive monomer, partially by interaction with 
Ku70 protein (Sawada et al., 2003a;Sawada et al., 2003b), but in 
the apoptotic cell, the conformation of Bax is changed and it is 
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inserted into the mitochondrial outer membrane as an oligomer 
(Gross et al., 1998; Hsu et al., 1997b; Korsmeyer et al., 2000; 
Putcha et al., 1999; Smaili et al., 2001; Wolter et al., 1997). Bak, 
a mitochondrial resident pro-apoptotic protein, might undergo a 
similar conformational change, oligomerization and activation 
(Griffiths et al., 1999; Wei et al., 2000; Korsmeyer et al., 2000). 
Full-length Bid is inactive in healthy cells, but in apoptotic cells, it 
is activated by proteolytic cleavage by caspase-8 (Li et al., 1998; 
Luo et al., 1998; Muchmore et al., 1996; Eskes et al., 2000), 
granzyme B (Heibein et al., 2000; Barry et al., 2000), cathepsins 
(Reiners, Jr. et al., 2002; Stoka et al., 2001) or calpain (Li et al., 
2000; Chen et al., 2001; Gil-Parrado et al., 2002; Mandic et al., 
2002). Truncated Bid (tBid) is further fully activated by 
myristoylation of its N-terminus that anchors tBid to the outer 
mitochondrial membrane (Zha et al., 2000). tBid is shown to 
participate in activation of Bax and Bak (Desagher et al., 1999; 
Kluck et al., 1999; Korsmeyer et al., 2000; Wei et al., 2000), but 
it can also generate channels to the mitochondrial membranes 
by itself (Schendel et al., 1999; Epand et al., 2002). Bad is 
phosphorylated in healthy cells and sequestered in the cytosol 
by virtue of association with the scaffolding protein 14-3-3 (Zha 
et al., 1996; Harada et al., 1999; Tan et al., 2000; Zhou et al., 
2000), whereas in apoptotic cells, Bad is dephosphorylated, 
translocated to the mitochondria, where it interacts with Bcl-xL 
(Yang et al., 1995; Zha et al., 1997; Bae et al., 2001). Bim and 
Bfm are sequestered by binding to dynein light chains in dynein 
motor complex (Bim) or myosin motor complex (Bfm) that are 
associated with the microtubules or actin cytoskeleton, 
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respectively (Puthalakath et al., 1999; Puthalakath et al., 2001). 
In some types of cells (e.g. cerebellar granule neurons and 
sympathetic neurons), Bim is also transcriptionally induced 
(Putcha et al., 2001; Whitfield et al., 2001; Harris and Johnson, 
Jr., 2001). Similarly, DP5/Hrk, Noxa, Puma and EGL-1 are 
regulated primarily at the transcriptional level (Kanazawa et al., 
1998; Imaizumi et al., 1999; Oda et al., 2000; Schuler et al., 
2003; Nakano and Vousden, 2001; Conradt and Horvitz, 1998; 
del Peso et al., 2000). All these BH3-only proteins directly or 
indirectly activate Bax/Bak and induce oligomerization of 
Bax/Bak at mitochondria. Bax and/or Bak then induce 
mitochondrial membrane permeabilization whereby the 
apoptogenic proteins are released to the cytosol (Desagher et 
al., 1999; Goping et al., 1998; Gross et al., 1998; Hsu et al., 
1997b; Korsmeyer et al., 2000; Nechushtan et al., 2001; Putcha 
et al., 1999; Smaili et al., 2001; Wolter et al., 1997). However, it 
is not fully understood how the conformational change of Bax or 
Bak is induced in apoptotic cells and the mechanism how Bax 
translocates to mitochondria, although the involvement of tBid 
and Bim has been demonstrated in several cases (Huang and 
Strasser, 2000; Desagher et al., 1999; Eskes et al., 2000; 
Brustovetsky et al., 2003; Wei et al., 2000; Putcha et al., 2001; 
Whitfield et al., 2001).  
The mechanism by which Bax and/or Bak mediate the 
release of cytochrome c and other death inducing factors is 
under hot debate (Martinou and Green, 2001; Robertson et al., 
2003). Two prevailing models have been postulated: The first 
model involves formation of the channels to mitochondria by 
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directly activated Bax and/or Bak with (Crompton, 1999; Marzo 
et al., 1998a; Marzo et al., 1998b; Marzo et al., 1998c; Narita et 
al., 1998; Shimizu et al., 1999; Schendel et al., 1998; Belzacq et 
al., 2003; Roucou et al., 2002a) or without the involvement of 
other mitochondria proteins (Basanez et al., 1999; Saito et al., 
2000; Shimizu and Tsujimoto, 2000; Eskes et al., 1998; 
Antonsson et al., 2000). The second model involves the swelling 
of mitochondrial matrix and subsequent disruption of 
mitochondrial outer membrane (Vander Heiden et al., 2001). It 
was reported recently that interactions of activated Bax with 
mitochondrial lipids, in particular cardiolipin, in the absence of 
any other protein is sufficient to generate openings to the 
membrane and release cytochrome c (Epand et al., 2002; 
Kuwana et al., 2002; Ott et al., 2002).  
Recent studies with the synthetic BH3 peptides have 
furthered our understanding to the actions of Bcl-2 family 
proteins. BH3 peptides of pro-apoptotic proteins Bax, Bak, Bid, 
Bad and Bim could bind differentially to multidomain anti- or pro-
apoptotic Bcl-2 proteins and potently induce cell death, whereas 
the BH3 peptides of anti-apoptotic Bcl-xL and Bcl-2 are inactive 
or less potent (Letai et al., 2002; Holinger et al., 1999; Polster et 
al., 2001; Moreau et al., 2003; Vieira et al., 2002; Shangary and 
Johnson, 2002; Schimmer et al., 2001). Based on the preference 
of the binding partner, BH3-only proteins could be further 
categorized into two subgroups. The ‘Bid-like’ subgroup binds to 
and activates Bak and Bax. Bid-like subgroup can also bind to 
the anti-apoptotic protein Bcl-2 and Bcl-xL, however, where these 
peptides are sequestered and unable to function. The other 
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group, known as the ‘Bad-like’ subgroup, can not bind to and 
activate Bak or Bax, instead they bind to and inactivate anti-
apoptotic members such as Bcl-2, Bcl-xL and thereby increase 
the susceptibility of cells to a death signal. Bad-like proteins can 
synergize the cell death with Bid-like proteins by releasing the 
latters from the sequestration by anti-apoptotic members. Thus, 
BH3-only proteins are considered as upstream initiators of 
apoptosis and could activate downstream multidomain Bax and 
Bak, which serve as essential effectors in mitochondrial death 
pathway (Wei et al., 2001). Anti-apoptotic members seem to 
function by sequestering BH3-only proteins, thereby preventing 
the activation of Bax and Bak (Cheng et al., 2001). In support of 
this scenario, Bax/Bak double deficient cells were resistant to 
apoptosis induced by a wide variety of death stimuli. Bid and 
other BH3-only proteins failed to induce apoptosis in Bax/Bak 
double deficient cells (Wei et al., 2001; Zong et al., 2001)  
 
1.5. Caspase family 
 
Despite the diversity of death stimuli and immediate signal 
transduction pathways, the execution of apoptosis is mostly 
implemented by a family of cysteine proteases, called caspases 
(cysteinyl aspartate-specific proteinases) (Li and Yuan, 1999; 
Earnshaw et al., 1999; Denault and Salvesen, 2002; Thornberry 
et al., 1997). They cleave cellular substrates after specific 
aspartate residues, while three amino acids upstream of the 
aspartate determine the substrate specificity of individual 
caspase (Cerretti et al., 1992; Lazebnik et al., 1994; Takahashi 
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et al., 1996; Sakahira et al., 1998; Thornberry et al., 1997). At 
least fourteen members of caspase family have been identified 
in mammalian cells (Figure 3). Caspases can be divided into 
inflammatory caspases (caspase-1, 4, 5 and 11) (Wang et al., 
1998; Yuan et al., 1993) that are essential for the maturation of 
cytokines, and apoptotic caspases (caspases-2, 3, 6, 7, 8, 9, 10 
and 12). Apoptotic caspases can in turn be divided into initiator 
caspases (-2, -8, -10, -9, -12) (Slee et al., 1999) and effector 
caspases (-3, -6, -7). Initiator caspases have long prodomains 
with the motifs that are necessary for their recruitment to the 
activation platforms and subsequent activation. The long 
prodomains of caspase-8 and caspase-10 harbour two tandem 
repeats of death effector domains (DEDs), which mediate the 
homophilic interactions between these caspases and DED-
containing adaptor protein such as FADD (Vincenz and Dixit, 
1997). The pro-domain of caspase-9 and 12 contain caspase 
recruitment domains (CARDs) mediating the interaction of these 
caspases with other CARDs containing molecules, e.g. Apaf-1 
(Zou et al., 1997; Hofmann et al., 1997; Li et al., 1997).   
Caspases are synthesized as zymogens or pro-caspases, each 
of which contains a pro-domain and a protease domain that 
comprises a large subunit and a small subunit. A cysteine 
residue in the active center of caspase is critical for the catalytic 
activity. Activation of a caspase involves two proteolytic steps: 
cleavage at the site between small and large subunit and then 
cleavage at the site between pro-domain and large subunit. Two 
large and two small subunits form a heterotetramer representing 
an active caspase. Following death signals, initiator caspases 
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are activated by an increase in their concentration in the 
activation platforms such as DISC or apoptosome where the 
induced-proximity facilitates their autocatalytic processing and 
activation (Muzio et al., 1998; Salvesen and Dixit, 1999; Strasser 
et al., 2000). In the death receptor pathway, pro-caspase-8 or -
10 is recruited to DISC via the DED domain, and thereafter 
proteolytically activated. In the mitochondrial pathway, release of 
cytochrome c from the mitochondria to the cytosol leads to 
assembly of the apoptosome that recruits pro-caspase-9 via the 
CARD domain. In contrast to other pro-caspases, the pro-
caspase-9 could be activated without processing. Most of the 
active caspase-9 remains complexed with Apaf-1 (Stennicke et 
al., 1999; Acehan et al., 2002). Activated initiator caspases then 
activate downstream effector caspases such as caspase-3, -6 
and -7. Collective action of the executioner caspases finally 
brings about the apoptotic death of the cell. Caspase-2 is a 
CARD-containing caspase but with effector-caspase substrate 
cleavage preference (DXXD), suggesting that it may function as 
both initiator and effector caspase. Consistently, recent studies 
have demonstrated that caspase-2 could function as initiator 
caspase upstream or independent of mitochondria (Lassus et al., 
2002; Robertson et al., 2002; Guo et al., 2002; Baliga and 
Kumar, 2003; Read et al., 2002).  
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Figure 3. Modular structure of the caspases. The pro-caspases 
contain a pro-domain and the domains of large and small subunit. The 
caspases are structurally and functionally divided into initiator 
caspases and effector (executioner) caspases. Pro-domains of the 
initiator pro-caspases contain the association domains (either caspase 
recruitment domains or death effector domains) that are required for 
the recruitment to the caspase activation platforms. Short pro-domains 
of the effector caspases do not contain the association domains. 
Caspase activation involves proteolytic separation of the three 
domains. The two large and two small subunits associate as the 
homodimers of heterodimers, whereas the catalytic center of the 
enzyme is formed by both large and small subunit. Activation of 
caspase-9 does not exceptionally involve proteolytic cleavage (not 
shown). 
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A large number of cellular substrates cleaved by activated 
caspases during apoptosis have been identified, but their actual 
contributions to apoptotic death are clear only in few cases. 
Caspases are highly specific endoproteinases, which do not 
degrade the proteins totally, but rather generate discrete 
fragments that are not further processed. Some proteins are 
activated by the cleavage whereas others are inactivated. For 
example, caspases themselves are the substrates of activated 
caspases. Among the cellular victims of caspases are many 
cytoskeleton components such as Gas-2, Fodrin, Actin, gelsolin, 
β-catenin and focal adhesion kinase. Cleavage of these 
substrates probably leads to detachment of the cells from the 
substrate and cell shrinkage. Cleavage of actin-binding protein 
gelsolin by caspase-3 generates a constitutively active fragment 
that can depolymerize cytoskeletal actin. In addition, two kinases 
ROCK-I (Rho-activated serine/threonine kinase) and PAK-2 
(p21-activated kinase) are cleaved and constitutively activated 
by caspase-3 and are thought to participate in the loosening of 
cortical cytoskeleton that leads to membrane blebbing (Fischer 
et al., 2003). Cleavage of ICAD (Wolf et al., 1999) by caspase-3 
during apoptosis releases an apoptotic endonuclease CAD, 
which is then translocated to the nucleus where it cleaves DNA 
into nucleosomal fragments with a length of multiples of 180-200 
base pair. When analysed by agarose gel electrophoresis, the 
DNA fragments display a characteristic pattern of ladder that is 
widely used to detect apoptotic cells (Sakahira et al., 1998; Li et 
al., 1998; Liu et al., 1997). Bid is cleaved and activated by 
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caspase-8 and amplifies the apoptotic signal at the mitochondria 
(Li et al., 1998).  
Targeted gene disruption studies have revealed that 
caspases play essential roles in development, immune 
regulation, proliferation and apoptosis (Puthalakath and 
Strasser, 2002; Wang and Lenardo, 2000). But for a given death 
signal, a specific caspase might be essential in one cell type but 
dispensable in another. Female mice deficient in caspase-2 
(Bergeron and Yuan, 1998) had over-accumulation of germ cells, 
indicating that caspase-2 was required for apoptosis in oocytes. 
These mice also had a decreased number of facial motor 
neurons. Sympathetic neurons from caspase-2 deficient mice 
showed increased sensitivity to NGF deprivation induced 
apoptosis but remained resistant to apoptosis induced by β-
amyloid treatment. The diverse effects of caspase-2 deletion on 
sympathetic neurons were attributed to the compensatory 
overexpression of caspase-9 and Smac/DIABLO (Troy et al., 
2001). Mice deficient in caspase-3 (Kuida et al., 1996), caspase-
9 (Hakem et al., 1998) or Apaf-1 (Yoshida et al., 1998) had 
profound developmental defects in the forebrain, where the 
neurons were massively accumulated, resulting in exencephaly. 
However, in all other brain regions, and in non-neuronal tissues, 
the programmed cell death had occurred normally and the 
organs had normal shape (Zaidi et al., 2001; Roth and D'Sa, 
2001; D'Sa-Eipper et al., 2001). Moreover, the lymphocytes 
derived from caspase-3, 9-deficient mice died normally to 
response to several apoptotic stimuli (Marsden et al., 2002), 
suggesting the existence of several parallel or redundant death 
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pathways. Mice deficient in caspase-8 died around embryonic 
day 12,5 due to the defect in heart development. The number of 
hematopoietic precursors was dramatically reduced due to 
reduced proliferative capacity. In line with in vitro data, 
fibroblasts from caspase-8 deficient mice were completely 
resistant to death receptor mediated apoptosis. Thus, besides its 
critical role in apoptosis, caspase-8 is essential for the growth 
and differentiation of heart muscle and hematopoietic 
progenitors cells (Varfolomeev et al., 1998). Caspase-8 mutation 
in human was reported with an arginine to a tryptophan change 
at residue 248 in the p18 protease subunit of caspase-8. This 
mutation reduced the stability of caspase-8 and produced an 
inactive caspase-8. Homozygous patients manifested defective 
lymphocyte apoptosis and homeostasis, but in contrast to the 
mutation in caspase-10 and CD95, the patients also had 
immunodeficiency and the resultant opportunistic infections 
(Chun et al., 2002). Caspase-10 mutation patients (Wang et al., 
1999a) developed autoimmune lymphoproliferative syndrome, 
characterized by defective in lymphocyte apoptosis, 
lymphadenopathy, splenomegaly and autoimmunity, similar to 
that seen in CD95/Fas mutation (Fisher et al., 1995; Rieux-
Laucat et al., 1995; Kasahara et al., 1998).  
  Knockouts of other caspases showed no obvious 
phenotype and might need further analysis. 
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1.6. Caspase-independent death 
 
Although caspases are critically implicated in mediating most of 
apoptosis, an increasing body of evidence indicates the 
existence of caspase independent pathways in regulating cell 
death (Green and Kroemer, 1998). Caspase inhibitors could 
block apoptosis only in certain cell types in response to certain 
death stimuli. For example, broad-range caspase inhibitor BAF 
could rescue sympathetic neurons from apoptosis induced by 
NGF removal, but failed to protect the same neurons from death 
induced by overexpression of Bax or Bak, although caspase-3/9 
activation and nuclear fragmentation were clearly blocked 
(McCarthy et al., 1997; Miller et al., 1997; Xiang et al., 1996). In 
yeast, there are no endogenous caspases (and also Bcl-2 family 
proteins or Apaf-1-like proteins). Nevertheless, overexpression 
of Bax, Bak or Ced-4 induced yeast cell death with the 
morphologies resembling mammalian apoptosis (Jurgensmeier 
et al., 1997; James et al., 1997). There are reports of 
nonapoptotic death that are caspase-independent and involve 
increased autophagy and cytoplasmic vacuolization (Clarke, 
1990; Xue et al., 1999). These caspase-independent death 
pathways are currently poorly studied. A number of apoptogenic 
factors are released from mitochondria during apoptosis that 
participate in the cell death without caspase involvement. Among 
them, apoptosis-inducing factor (AIF) migrates to nucleus and 
participates in the chromatin condensation, DNA fragmentation 
and cell death (Cande et al., 2002; Lorenzo et al., 1999; 
Penninger and Kroemer, 2003). Other proteases such as 
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calpains (Lankiewicz et al., 2000; Nakagawa and Yuan, 2000) 
and cathepsins (Kagedal et al., 2001; Katunuma et al., 2001; 
Leist and Jaattela, 2001; Reiners, Jr. et al., 2002; Stoka et al., 
2001) but also proteasome (Sadoul et al., 1996; Wojcik, 1999) 
are reported to participate in programmed cell death 
independent of caspases.  
 
1.7. Inhibitor of apoptosis protein family    
 
The inhibitor of apoptosis (IAP) family of proteins represents an 
important class of regulators of programmed cell death 
(Salvesen and Duckett, 2002). Initially identified in baculoviruses 
(Birnbaum et al., 1994; Crook et al., 1993), now the members of 
IAP family have been identified in mammals (XIAP, c-IAP1, c-
IAP2, NAIP and Survivin) (Rothe et al., 1995; Liston et al., 1996; 
Uren et al., 1996), in Drosophila (DIAP1, DIAP2 and Deterin) 
(Hay et al., 1995) and in yeast. All IAPs contain one to three 
baculovirus IAP repeat (BIR) domains, which have a 
characteristic signature sequence with a conserved spacing of 
cysteine and histidine (CX2CX16HX6C). Some of IAPs also 
contain a C-terminal Ring finger domain. IAPs bind and directly 
inhibit caspases (Deveraux et al., 1999; Uren et al., 1998). 
Overexpression of IAPs could prevent apoptosis induced by a 
variety of death stimuli. BIR domains are critical for the caspase 
inhibitory activity of IAP proteins (Duckett et al., 1996; Takahashi 
et al., 1998). Structural and site-directed mutational analyses 
have revealed that the BIR3 domains of XIAP and c-IAP1 are 
responsible for binding and inhibiting caspase-9 both in its 
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proform or active form (Sun et al., 2000). The linker region and 
BIR2 domain are essential for XIAP to bind to active caspase-3 
or caspase-7 and inhibit their enzymatic activity (Deveraux et al., 
1999; Fesik, 2000; Roy et al., 1997; Sun et al., 1999; Takahashi 
et al., 1998). Several IAPs including XIAP have also a C-terminal 
RING-finger domain that can function as E3 ligase involved in 
the ubiquitination and subsequent proteasomal degradation of 
the proteins (Joazeiro and Weissman, 2000). The main target for 
such degradation has been shown to be XIAP itself (Yang and 
Li, 2000). Thus, in healthy cells, caspases are bound and 
inactivated by IAP proteins as an additional checkpoint to 
prevent their accidental activation. In apoptotic cells, however, 
IAP blockage is released by their degradation in the proteasome. 
Recently, another way to release IAP blockage from caspases 
has been found, that involves two related proteins: 
Smac/DIABLO and Htra2/Omi. These proteins are released from 
the mitochondria to the cytosol in apoptotic cells, and they 
compete with caspases for binding to IAP proteins, thereby 
releasing the caspases that can now be recruited to activating 
platforms (Chai et al., 2000; Verhagen et al., 2000; Srinivasula et 
al., 2001; Suzuki et al., 2001; Hegde et al., 2002). Survivin could 
also bind and inhibit caspase-9, but besides its anti-apoptotic 
activity, survivin is implicated in the regulation of chromatin 
segregation (Ambrosini et al., 1997; Li et al., 1998).  
Targeted gene disruption of individual IAPs has been 
reported in flies, C. elegans and mouse. Disruption of DIAP1 is 
sufficient to trigger widespread apoptosis, resulting embryonic 
lethality in Drosophila (Wang et al., 1999b). In sharp contrast, 
 37 
individual IAP transgenic and knockout mice and C. elegans 
display no obvious phenotype related to aberrant apoptosis, 
suggesting that individual IAPs play less important role in 
regulating programmed cell death in mammals and C. elegans 
(Harlin et al., 2001; Holcik et al., 2000). Also, no obvious 
phenotype was observed in the DIABLO/Smac null mice (Okada 
et al., 2002).  
 
1.8. Participation of the organelles in the apoptosis  
 
It has become increasingly evident that apoptosis is an elaborate 
multilevel process. Depending on the cell type and death 
stimulus, eventually most of cellular compartments, including 
plasma membrane, cytoskeleton, mitochondrion, endoplasmic 
reticulum, nucleus, Golgi apparatus and lysosome, are involved 
in the apoptotic process. There are extensive crosstalks among 
different organelles during apoptosis. In response to distinct 
stimulus, each organelle locally initiates signal transduction 
pathways and emits signals that ensure inter-organelle 
crosstalks and orchestrate global apoptotic responses. Once a 
critical threshold of damage has been reached, the cell executes 
its self-destruction by engaging a common death pathway that 
culminates in the activation of caspase cascade (Martinou and 
Green, 2001; Ferri and Kroemer, 2001b; Newmeyer and 
Ferguson-Miller, 2003; Bratton and Cohen, 2001).    
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1.8.1. Mitochondria 
Mitochondria have turned out to play a central role in regulating 
apoptosis (Kroemer and Reed, 2000; Martinou and Green, 2001; 
Newmeyer and Ferguson-Miller, 2003). The release of 
apoptogenic proteins from mitochondrial intermembrane space 
inevitably leads to cell death. Numerous pro-apoptotic signal 
transduction pathways converge on mitochondria, which act as 
the receiving platform, integrating a wide range of apoptotic 
stimuli and relaying these to the appropriate downstream 
signaling cascades. The most studied factors that relay death 
stimuli to mitochondria are BH3-only proteins and pro-apoptotic 
protein Bax. Following death signals, pro-apoptotic Bcl-2 
proteins translocate to mitochondria from distinct cellular 
compartments and induce mitochondrial membrane 
permeabilization: Bid, Bad and Bax from cytosol, or Bim and Bmf 
from cytoskeleton elements (Gross et al., 1999; Cory and 
Adams, 2002; Cory and Adams, 2002). Bid also mediates the 
death signals from plasma membrane death receptors (Li et al., 
1998; Luo et al., 1998) and lysosomes (Katunuma et al., 2001; 
Reiners, Jr. et al., 2002; Stoka et al., 2001) to mitochondria. 
Mitochondria, together with ER, play an important role in 
regulating intracellular calcium homeostasis, which is critically 
implicated in apoptotic process. Mitochondrial accumulation of 
calcium above certain threshold could perturb oxidative 
phosphorylation and lead to an increased production of reactive 
oxygen species (ROS) and mitochondrial dysfunction (Hajnoczky 
et al., 2003; Newmeyer and Ferguson-Miller, 2003; Duchen, 
2000; Smaili et al., 2000).  
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1.8.2. Endoplasmic reticulum 
Endoplasmic reticulum (ER) participates in the initiation of 
apoptosis by at least two different mechanisms: unfolded protein 
response (UPR) and Ca2+ signaling (Pahl, 1999; Kaufman, 
1999). Caspase-12 is specifically localized on ER membrane, 
and is activated by ER stress and the mobilization of intracellular 
Ca2+ ion stores. Caspase-12 is proteolytically activated by m-
calpain, a Ca2+-responsive cytosolic cysteine protease, which 
also cleaves Bcl-xL, converting it into a pro-apoptotic protein. 
Caspase-12 knockout cortical neurons were resistant to β-
amyloid protein-mediated apoptosis (Nakagawa et al., 
2000;Nakagawa and Yuan, 2000). The inhibition of SERCA 
(sarco/endoplasmic reticulum Ca2+-ATPase) by thapsigargin 
perturbates ER Ca2+ homeostasis and induces apoptosis. 
Increases in Ca2+ can activate calcineurin that dephosphorylates 
Bad and causes it to translocate to mitochondrial membrane. 
Compelling evidences suggest that Bcl-2 family proteins critically 
regulated ER function. Bcl-2, Bax and Bak are reported to 
localize to ER and control Ca2+ homeostasis and apoptosis 
(Hajnoczky et al., 2003; Scorrano et al., 2003; Nutt et al., 2002; 
Pinton et al., 2002; Pinton et al., 2000; Foyouzi-Youssefi et al., 
2000; Vanden Abeele et al., 2002). 
 
1.8.3. Nucleus 
Cells respond to DNA damage by inducing DNA repair, growth 
arrest or apoptosis. One of the key mediators of these responses 
is the tumor suppressor p53, a transcription factor normally 
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sequestered by the interaction with Mdm-2 protein. DNA 
damages lead to phosphorylate p53 or MDM2, preventing two 
proteins from interacting, thus stabilizing and activating p53. 
Depending on the cell type, a variety of p53-targeted genes have 
been reported. Activation of cyclin-dependent kinase inhibitor 
p21 by p53 accounts mostly for cell cycle arrest after DNA 
damage. Activation of p53 leads to the up-regulation of pro-
apoptotic proteins such as Bax, PUMA, Noxa, Bim and DP5/Hrk, 
all of which translocate to mitochondria and induce cell death. 
p53 induces the expression of mitochondrial enzymes such as 
proline oxidase that locally generates reactive oxgene species, 
leading further membrane damage. Other apoptosis-related 
genes activated by p53 include p53AIP1, Apaf-1, Fas, DR5, and 
PTEN (Shen and White, 2001; Schuler and Green, 2001; 
Vousden and Lu, 2002). p53 is also implicated in cellular 
responses to a variety of cellular stresses other than DNA 
damage, although the signalling pathways by which these insults 
activate p53 are mostly unknown. p53 has recently been 
reported to translocate to mitochondria where it promotes 
apoptosis by directly interacting with Bcl-xL (Mihara et al., 2003). 
 
1.8.4. Golgi complex 
Substantial evidence implicates Golgi complex as an important 
player in apoptosis. Golgi membranes contain a number of 
apoptosis-signaling proteins, such as caspase-2, death 
receptors (TNFR1, CD95, TRAIL-R1 and TRAIL-R2), Beclin and 
GD3 synthase. Death receptors could translocate to plasma 
membrane during apoptosis (Bennett et al., 1998). GD3 
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synthase catalyses the conversion of ceramide to GD3, which 
could translocate to mitochondria and induce mitochondrial 
membrane permeabilization (Rippo et al., 2000).  Caspase-2 
plays a key role in the destruction of the Golgi complex during 
apoptosis (Mancini et al., 2000). 
 
1.8.5. Lysosomes 
Lysosomes participate in apoptosis by releasing lysosomal 
proteases such as cathepsins and by local generation of 
ceramide. Some lysosomotropic agents, which could accumulate 
in lysosomes and cause damage to the lysosomal membrane, 
have been reported to induce apoptosis. Lysosomal proteases 
were reported to translocate to cytosol during apoptosis, which 
precede the release of cytochrome c. Microinjection of cathepsin 
D causes caspase activation and apoptosis. It has been 
demonstrated that caspase activation by lysosomes occurred 
through cleavage of Bid by lysosomal proteases (Katunuma et 
al., 2001; Stoka et al., 2001; Leist and Jaattela, 2001; Salvesen, 
2001; Bursch, 2001).  
 
1.8.6. Cell volume regulation 
Cell shrinkage is one of the hallmarks of apoptosis. Apoptotic 
cell volume decrease is caused by loss of intracellular ions, 
especially potassium, which is regulated by the plasma 
membrane ion channels and transporters. Excessive efflux of 
intracellular K+ during early phase of apoptosis is required for 
cell death whereas blockage of K+ channels in the plasma 
membrane could significantly attenuate the cell shrinkage and 
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cell death. Maintenance of a normal intracellular K+ 
concentration is required for suppression of the activity of 
caspases and nucleases (Hughes et al., 1997; Bortner et al., 
1997; Dallaporta et al., 1998; Bortner and Cidlowski, 2002). Thus 
loss of intracellular K+ early in apoptosis is necessary for the 
progression of apoptotic death program. It is reported that 
cytoplasmic application of exogenous cytochrome c or 
translocation of cytochrome c from mitochondria to the cytosol 
could directly or indirectly open K+ channels by oxidizing the 
channel protein, leading to the loss of intracellular K+ (Platoshyn 
et al., 2002). High extracellular K+ concentration could prevent 
K+ efflux and protect cells from apoptosis in a variety of model 
system, such as cultured cerebellar granule neurons and 
sympathetic neurons (Skaper and Varon, 1983; Edwards et al., 
1991; Julio et al., 1999).  
 
1.9. Alternative splicing and apoptosis 
 
Tissue or cell type-specific alternative splicing is a genetic 
process whereby a single pre-mRNA is processed into multiple 
mRNA isoforms differing in their precise combination of exon 
sequences. Alternative splicing is thought to be important in 
increasing the diversity of the proteins controlling multiple 
cellular functions, including programmed cell death (Jiang and 
Wu, 1999). A number of genes involved in the programmed cell 
death are spliced into functionally different or even antagonistic 
isoforms with distinct tissue or cell specificity as well as 
subcellular distribution, thereby providing a fine-tuning 
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modulation of cell death program. Alternative splicing may also 
influence the mRNA stability and/or translation.  
Splice variants encoding different protein isoforms have 
been described for several Bcl-2 family members. In most cases, 
as for Bcl-xß (Yang et al., 1997), Bcl-xγ (Yang et al., 1997), Bcl-
x∆TM (Fang et al., 1994), Bax-ß (Oltvai et al., 1993), Bax-σ 
(Schmitt et al., 2000) , Bax-ω (Zhou et al., 1998), Bcl-2ß (Negrini 
et al., 1987), the changes involve the C-terminal regions of the 
proteins, leaving the BH domains unaltered. In other splice 
variants, regions encoding one or more BH domains are missing. 
For example, Bax-є (Shi et al., 1999) lacks the BH2 domain; 
Bax-δ (Apte et al., 1995) lacks the BH3 domain; and, BokS (Hsu 
and Hsueh, 1998) contains only the BH2 domain and a 
composite domain consisting of half of the BH3 domain and half 
of the BH1 domain. The functionality of these splice variants 
remains mainly unchanged. Ten Bim isoforms have been 
described, of which, BimS, BimAD and Bimγ showed strong 
apoptotic activity (O'Connor et al., 1998; Bouillet et al., 2001; U 
M et al., 2001; Marani et al., 2002). There are, however, a few 
cases where alternative splicing generates shorter BH3-only 
variants of multi-BH domain Bcl-2 family proteins, whose activity 
is converted opposite to that of the longer isoform. So far, such 
splice variants have been described only for the anti-apoptotic 
proteins Bcl-x (Boise et al., 1993) and Mcl-1 (Bae et al., 2000; 
Bingle et al., 2000). The multi-BH domain Bcl-xL and Mcl-1L 
isoforms protect against apoptosis, whereas their short BH3-only 
variants, Bcl-xS (which, however, possesses also a BH4 domain) 
and Mcl-1S, promote death. Bcl-GL containing BH3 and BH2 
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domains has only minor effect on apoptosis, whereas its BH3-
only isoform, Bcl-GS (Guo et al., 2001) has strong death-
promoting activity. Many members of death receptor family have 
multiple alternative variants. For example, alternative splicing of 
Fas mRNA generates several soluble Fas receptors and the 
receptors without cytoplasmic death domain, some of which 
function as decoy receptors or dominant negative blockers 
antagonizing the function of Fas (Cheng et al., 1994; Liu et al., 
1995; Hughes and Crispe, 1995; Cascino et al., 1995; Papoff et 
al., 1996; Jenkins et al., 2000; Carla et al., 2003). Several 
alternative spliced forms of caspases have also been reported 
where the splicing variants function in opposite way. For 
example, caspase-2 (Wang et al., 1994; Kumar, 1995; Cote et 
al., 2001), caspase-9 (Fujita et al., 1999; Seol and Billiar, 1999; 
Srinivasula et al., 1999; Angelastro et al., 2001) and caspase-8 
(Hu et al., 1997; Scaffidi et al., 1997) are important apoptosis 
inducing proteins, however their alternatively spliced variants are 
anti-apoptotic. In C. elegans, CED-4 serves as important adaptor 
protein linking CED-9 (Bcl-2 homologue) and CED-3 
(mammalian homologue of caspase-3). Two alternative variants 
of CED-4, CED-4S and CED-4L, have been reported, with CED-
4S being the predominant form. CED-4S is pro-apoptotic 
whereas CED-4L is anti-apoptotic (Shaham and Horvitz, 1996; 
Chaudhary et al., 1998). Apaf-1, a mammalian homologue of 
CED-4, also has at least two isoforms, Apaf-1L and Apaf-1. But 
unlike CED-4, both Apaf-1 and Apaf-1L induce cell death (Hahn 
et al., 1999; Hu et al., 1999; Zou et al., 1999; Walke and Morgan, 
2000). A splice isoform, Smac-β, lacking mitochondrial targeting 
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sequence and the IAP binding motif, was reported to promote 
apoptosis as efficiently as full-length Smac in some cells 
(Roberts et al., 2001), suggesting that Smac/DIABLO could 
promote cell death without the interaction with IAP proteins. 
However, in the sympathetic neurons, the short isoform of 
Smac/DIABLO had no apoptotic activity (Deshmukh et al., 2002). 
Alternative splicing changes the tissue or cell specificity of the 
gene expression. Thus, Bcl-xL is widely expressed whereas the 
expression of its alternative variant Bcl-xS is more restricted.  
Whereas Bcl-GL is expressed in many tissues, its BH3 isoform 
Bcl-GS is testis specific. Bimγ is most abundantly expressed in 
small intestine and colon. 
Although splice isoforms have described for many 
apoptosis-related genes, little is known of their biology. 
Surprisingly, although the proteins for “main” isoforms have been 
well demonstrated, the proteins for their alternative isoforms 
have mainly not found. For example, BimS, BimAD are only 
detected in 293 cell line, although their mRNAs are detected in 
many tissues. Endogenous Bcl-xS protein is hardly detected in 
most cases and endogenous proteins for Mcl-1S, BokS and 
caspase-2S are not shown. The reasons for the failure to detect 
endogeneous proteins for the isoforms of apoptosis-related 
proteins is not clear, although low levels of expression, the 
absence of constitutive translation, or short half-life of the 
proteins can be anticipated. Alternative splicing may also change 
the stability of mRNA, especially those transcripts with 
premature termination codon. The restricted expression pattern 
and overall low protein level make the study of these alternative 
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variants more difficult and challenging. Although their apparent 
role in fine-tuning control of programmed cell death, thus far, the 
significance of these small isoforms are largely ignored and 
unappreciated.   
 
1.10. Programmed cell death in the development of the 
nervous system 
 
Programmed cell death is a critical cellular event in construction 
of the nervous system. PCD eliminates the neurons excessively 
produced at earlier stages of development, thus sculpting the 
tissue shape, sharpening the borders of the brain compartments, 
keeping proper size of the neuronal populations and matching 
the neuronal number to the size of peripheral target. Various 
types of neurons, including motor neurons, sensory neurons, 
autonomic neurons, interneurons and projection neurons in the 
brain, spinal cord and peripheral nervous system die in large 
number during nervous system development. Overall, 20-80% of 
neurons produced during development of nervous system are 
later eliminated during programmed cell death stages 
(Oppenheim, 1991). Several hypotheses have been proposed to 
account for the biological role of neuronal death. Target-derived 
neurotrophic theory proposes that neurons are initially 
overproduced and compete for limited amounts of target-derived 
survival promoting or neurotrophic factors that actively promote 
their survival (Barde, 1989). By producing certain levels of 
neurotrophic factors that maintain certain number of innervating 
neurons, tissues get the required density of their innervation 
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(Purves et al., 1988). In line with this scenario, many neuronal 
populations undergo apoptosis during or shortly after 
establishing synaptic connections with their targets. 
Experimental increase or decrease of the size of the target 
tissues increased or decreased accordingly the size of the 
population of innervating neurons (Hamburger, 1993; 
Hamburger, 1975). Many secreted factors have been shown to 
act as neurotrophic factors. However, the best-characterized 
neurotrophic factors are those of neurotrophin family with nerve 
growth factor (NGF) as the classical example, especially in 
peripheral nervous system. Specific populations of sensory or 
sympathetic neurons are lost in the knockout mice lacking a 
particular neurotrophin or neurotrophin receptor. However, the 
central neurons are less affected in these knockout mice. It is 
currently believed that in addition to secreted neurotrophic 
factors, other signals promote survival of the neurons, including 
neurotransmitters released by afferent terminals and the 
electrical activity evoked by innervating axons (Korsching, 1993; 
Henderson, 1996; Oppenheim, 1996). In addition, apoptosis 
might be also involved in the establishment and refinement of 
synaptic network and neural circuitry. The initial neural 
connections in many central pathways are much more extensive 
and widespread. Those miss-targeted neurons or axons fail to 
get proper survival promoting factors or improper electric input 
(synaptic activity) and are eliminated by apoptotic process.  
Substantial death of migrating and differentiating neurons 
occurred within the developing CNS of mice deficient in genes 
required for repairing of the double-stranded DNA breaks. An 
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intriguing possibility of DNA recombination and subsequent 
cellular selection by apoptosis in the generation of neuronal 
diversity has been postulated (Chun and Schatz, 1999; Gilmore 
et al., 2000).  
 
1.11. Key regulators of apoptosis in nervous system 
 
Targeted-gene disruption studies have identified Bcl-2, Bcl-xL, 
Bax, caspase-9, caspase-3 and Apaf-1 as key regulators of 
apoptosis in mammalian nervous system. Overexpression of Bcl-
2 in transgenic mice decreased neuronal death and increased 
neuronal numbers in specific brain regions. Bcl-2 overexpressing 
neurons in culture are more resistant to certain death stimuli 
including trophic factor deprivation (Martinou et al., 1994). Bcl-2 
knockout resulted in only subtle neurodevelopmental 
abnormalities primarily affecting maintenance of selected 
neuronal subpopulations during postnatal life (Michaelidis et al., 
1996). Mice deficient in Bcl-xL died around embryonic day 13.5 
(E13.5) secondary to decreased hematopoietic cell survival. 
Extensive neuronal apoptosis was observed in the developing 
nervous system and was largely confined to the intermediate 
and marginal zones of the brain, which contain immature 
postmitotic neurons, but was not found in the ventricular zone 
containing predominantly neural precursor cells. Since the 
apoptotic immature neurons observed in the Bcl-xL-deficient 
nervous system had not yet established synaptic connections, 
lack of target-derived neurotrophic factors and/or synaptic 
activity could not account for the increased neuronal death 
 49 
(Motoyama et al., 1995). Bax is expressed at relatively high 
levels in both embryonic and adult brain. Bax deficiency reduced 
the apoptosis of target-derived neurotrophic factor-dependent 
neuronal subpopulations, such as spinal cord motor neurons and 
sympathetic neurons (Deckwerth et al., 1996; White et al., 1998). 
Additional Bax deficiency rescues the neuronal death observed 
in Bcl-xL-deficient mice, supporting the previous in vitro studies 
that Bax and Bcl-xL could counteract to regulate neuronal death 
(Shindler et al., 1997). Bak is another important proapoptotic 
protein of Bcl-2 family and it is shown to function redundantly 
and synergistically with Bax to regulate apoptosis in several 
model systems. Bak knockouts were found to be completely 
normal without any discernable phenotype. However, Bak/Bax 
double knockout led to perinatal lethality and the mice displayed 
multiple defects, including brain malformation and large 
accumulation of excess cells in central nervous systems, 
demonstrating that Bax and Bak function redundantly in 
regulation of apoptosis (Lindsten et al., 2000). Analyses of mice 
deficient in caspase-9, caspase-3 or Apaf-1 on the background 
of Bcl-xL deficiency have demonstrated a linear molecular 
pathway from Bcl-2 family proteins to the activation of Apaf-
1/caspase-9 and caspase-3 in regulating neuronal apoptosis. 
Deletion of any of these downstream proapoptotic molecules 
prevented neuronal caspase-3 activation and apoptosis in Bcl-xL 
deficient mice. However like Bax, none of these deficiencies 
rescued Bcl-xL deficient embryonic lethality, indicating that this 
conserved molecular pathway is not universally operative in all 
cellular context. Furthermore, Bcl-xL deletion failed to correct the 
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defect in neural stem cell death caused by the deletion of 
Caspase-3, 9 or Apaf-1, indicating that Bcl-xL plays little role in 
regulating neural stem cell apoptosis (Zaidi et al., 2001; Roth 
and D'Sa, 2001; Kuan et al., 2000). 
 
1.12. Sympathetic neurons as a model for the study of 
neuronal apoptosis 
 
NGF is the founder member of a family of structurally related 
secreted proteins termed neurotrophins that promote and 
regulate the survival of many populations of neurons in the 
peripheral nervous system during development. NGF is required 
for the survival of neonatal sympathetic neurons. The superior 
cervical ganglion (SCG) is a homogeneous population of 
sympathetic neurons whose neuronal genesis peaks at E18 in 
rodents and decreases thereafter as a consequence of naturally 
occurring neuronal death. SCG neurons become dependent on 
target-derived NGF at or shortly after E14 (Coughlin and Collins, 
1985). Programmed neuronal death occurs during first postnatal 
week in the SCG of rodents. Virtually all SCG neurons die during 
the programmed cell death stage in mice lacking NGF (Crowley 
et al., 1994) or NGF receptor trkA (Smeyne et al., 1994).  
Cultured NGF-dependent sympathetic neurons have been 
widely used in the study of neuronal apoptosis (Deshmukh and 
Johnson, Jr., 1997). It is an ideal in vitro model as it contains 
relatively homogeneous population of neurons and recapitulates 
the physiological cell death in vivo. Cellular and molecular 
events in sympathetic neurons undergoing apoptosis have been 
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extensively studied and well characterized. When the 
dissociated neurons from newborn mouse or rat SCG are grown 
in vitro with NGF for 5-7 days and then deprived of NGF, about 
90% of them die during three days with apoptotic morphological 
changes, including neurite fragmentation, irregular and atrophic 
cell body, membrane blebbing, nuclear condensation and DNA 
fragmentation (Deckwerth and Johnson, Jr., 1993; Edwards and 
Tolkovsky, 1994). Generally, cellular organelles remain relatively 
intact and show signs of degeneration only during the final 
stages of death, when the cell loses its structural integrity and 
die by secondary necrosis (Martin et al., 1988). NGF-deprived 
SCG neurons die asynchronously with different individual time-
schedules, the commitment point for death (time point after NGF 
deprivation when NGF re-addition rescues 50% of the neurons) 
being 22 hr (Deckwerth and Johnson, Jr., 1993). Sympathetic 
neuronal survival is dependent on a PI-3-kinase-Akt (serine-
threonine protein kinase B) signaling pathway as inhibitors of PI-
3-kinase (Yao and Cooper, 1995), such as wortmannin or 
LY294002, induce neuronal death in the presence of NGF (Yao 
and Cooper, 1995; Dudek et al., 1997). JNK (c-Jun N-terminal 
kinase) pathway is activated in sympathetic neurons deprived of 
NGF and is important for neuronal apoptosis, as dominant-
interfering mutants of c-jun inhibits neuronal death (Ham et al., 
1995; Whitfield et al., 2001; Estus et al., 1994; McCarthy et al., 
1997; Miller et al., 1997). Apoptosis in the NGF-deprived 
sympathetic neurons requires de novo induction of some “killer” 
genes, as inhibitors of mRNA or protein synthesis (e.g. by 
Actinomycin D or cycloheximide) efficiently blocks it (Martin et 
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al., 1988). BH3-only proteins Bim and DP5/Hrk are 
transcriptionally induced in NGF-deprived neurons and are 
required for their death (Putcha et al., 2001; Whitfield et al., 
2001; Biswas and Greene, 2002; Imaizumi et al., 1999). 
Certainly still other “killer” genes induced by NGF deprivation are 
not yet identified. 
It is established that NGF-deprived SCG neurons die by 
mitochondrial pathway. Thus, Bax is translocated to the 
mitochondria and induces release of cytochrome c from the 
mitochondria to the cytosol (Deckwerth et al., 1996; Deckwerth 
et al., 1998; Putcha et al., 1999; Martinou et al., 1999). Caspase-
9 caspase-3 and caspase-2 are activated (Deshmukh et al., 
2000; Deshmukh et al., 2002; Troy et al., 2001) and several 
death substrates, including chromosomal DNA are cleaved in the 
NGF-deprived SCG neurons (Edwards and Tolkovsky, 1994). 
Death of NGF-deprived neurons can be completely blocked by 
broad-range caspase inhibitor BAF, although cytochrome c has 
already been released to the cytosol (Martinou et al., 1999). 
Readdition of NGF to NGF-deprived, BAF-saved neurons 
rescued the neurons from death, and restored normal 
mitochondria with cytochrome c. In contrast to other studied 
cells, however, just cytosolic cytochrome c is not sufficient to 
trigger caspase activation in SCG neurons, as shown by 
microinjection of cytochrome c directly into the cytosol. Injected 
cytochrome c, however, killed the neurons that have been 
deprived of NGF for 15-20 hr (Deshmukh and Johnson, Jr., 
1998). Recently it was shown that release of Smac/DIABLO from 
the mitochondria in NGF-deprived neurons is necessary for their 
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death, presumably via releasing the caspases from the block by 
IAP proteins (Deshmukh et al., 2002).  
SCG neurons express multiple members of Bcl-2 
proteins. However, Bax seems to be the major determinant for 
their death, as Bax-deficient sympathetic neurons can survive in 
culture in the absence of NGF (Deckwerth et al., 1996; Putcha et 
al., 2002). Moreover, the massive neuronal loss caused by NGF 
or TrkA deletion in SCG is completely prevented by concomitant 
elimination of Bax (Middleton and Davies, 2001). Interestingly, 
the mature SCG neurons (after programmed cell death stage) do 
express Bax protein, but NGF deprivation does not induce 
translocation of Bax to mitochondria. These mature neurons, 
however can be induced to die by Bax overexpression, showing 
that they contain otherwise functional death machinery (Easton 
et al., 1997). However, another pro-apoptotic BH1-3 protein Bak 
seems to have no role in the developmental death of these 
neurons. Indeed, there is no reduced death in the SCG of Bak-
null mice. Moreover, the ability of Bak-deficient SCG neurons to 
release cytochrome c and die by NGF deprivation is completely 
normal (Putcha et al., 2002).  
SCG neurons also express multiple BH3-only proteins, 
including Bid, Bad, Bim, and DP5/Hrk, However, Bad and Bid do 
not participate in the death of NGF-deprived SCG neurons, and 
the purpose of their expression remains unclear (Putcha et al., 
2002). In contrast, Bim and DP-5/Hrk seem to be critically 
involved in the death of NGF-deprived SCG neurons. Both are 
transcriptionally induced by NGF removal and are required for 
cytochrome c release. This activity is, however, not manifested 
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in Bax-deficient neurons, showing that Bim and DP-5/Hrk act 
upstream of Bax (Imaizumi et al., 1999; Inohara et al., 1997; 
Putcha et al., 2001; Whitfield et al., 2001; Putcha et al., 2002).   
Thus, the cultured NGF-dependent sympathetic neurons 
from neonatal mouse or rat SCG are currently one of the best 
experimental models to study neuronal death, as they can be 
induced to die by physiological stimulus (removal of NGF), they 
can be experimentally manipulated (e.g. by microinjection) and 
they are relatively well studied.  
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2. AIMS OF THE STUDY 
 
• To characterize the alternative expression of Bak and N-
Bak in the glial and neuronal cells, respectively, to 
understand the role of the alternative splicing of Bak 
mRNA in the neurogenesis.  
 
• To study the mechanism(s) how N-Bak and its structural 
analogues regulate programmed death of the sympathetic 
neurons.  
 
• To characterize the apoptotic properties of two isoforms of 
Bad. 
 
• To investigate the differences in the role of Bcl-2 family 
proteins in the neurons and non-neuronal cells.  
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3. MATERIALS AND METHODS  
 
3.1. Cell cultures 
 
SCG from newborn to 1-day old mouse were digested with 
collagenase (2.5 mg/ml; Worthington), dispase (5 mg/ml; Roche 
Molecular Biochemicals), and trypsin (10 mg/ml; Worthington) for 
one hour at 37°C and dissociated mechanically with a siliconized 
glass Pasteur pipette. Non-neuronal cells were removed by 
extensive preplating. The neurons were cultured in 
polyornithine/laminin-coated plastic dishes or glass coverslips in 
a 1:1 ratio of nutrient mixture F-12 to Dulbecco’s modified 
Eagle’s medium (DMEM) (Life Technologies, Inc.) containing 3% 
fetal calf serum (Hyclone, Cramlington, United Kingdom), serum 
substitute and 30 ng/ml mouse 2.5 S NGF (Promega, Madison, 
WI). To eliminate few contaminating non-neuronal cells, 1 µM 
AraC or 3.3 µg/ml aphidicoline was included in culture medium 
for 5-6 days. The SCG neurons were maintained in vitro for 5-6 
days before subjected to experimental treatments.  
Hippocampi from E16 mice were dissociated with trypsin 
(0.25%) for 15 min at 37°C in Hanks’ balanced salt solution 
(HBSS) containing 1 mg/ml DNase I and 10 mM glucose, 
triturated with a siliconized glass Pasteur pipette, plated onto 
polyornithine-coated dishes, and grown in the Neurobasal 
medium (Life Technologies, Inc.) containing 10% fetal calf serum 
(HyClone). Next day, the serum medium was replaced by serum 
free medium containing Neurobasal medium, B-27 serum 
substitute and Glutamax (Life Technologies, Inc.). Granule 
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neurons were prepared from the cerebella of postnatal day 7-8 
(P7-8) mice, that were sliced into 1-mm pieces, and incubated at 
37°C for 15 min in HBSS containing 0.3% trypsin and 1mg/ml 
DNase I. The tissue was then washed three times with HBSS 
and triturated in HBSS containing 1 mg/ml DNase I. The cells 
were plated on poly-D-lysine-coated plastic dishes in Eagle’s 
basal medium with 10% FCS and depolarizing potassium (25 
mM KCl).   
Human neuroblastoma Neuro2A or monkey kidney 
epithelial COS-7 cells were grown in DMEM with 10% fetal calf 
serum. The cells at 50-80 % confluence were subjected to 
transfection or other experimental treatments.   
 
3.2. Reverse transcription-polymerase chain reaction (RT-
PCR) and cloning 
 
Total RNAs from rat and mouse tissues or from cultured cells 
were isolated with Trizol reagent (Life Technologies, Inc.). First 
strand cDNAs were synthesized using dN6 random primers 
(Roche Molecular Biochemicals) with Superscript II (Life 
Technologies, Inc.). 2 µl cDNA were amplified by PCR with the 
High Fidelity PCR system (Roche Molecular Biochemicals). The 
primers used for respective cDNAs are listed in Table 1. PCR 
was performed for 30-45 cycles with the following program: 95°C 
for 45 s, 60°C for 45 s, and 72°C for 45 s. PCR products (20 µl) 
were analyzed by agarose gel electrophoresis. DNA fragments 
of interest were excised and cloned into the vector as indicated. 
For detailed cloning strategies, refer to original papers. Amino 
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acid changes L76E and D81A were created with Quikchange 
Directed-Mutagenesis Kit (Stratagene) using respective 
constructs as templates.  
 
Table 1. List of primers used in this study 
CDNA Primers  
Bak Forward  5´-ccaccatggcatctggacaaggaccag 
 Reverse  5´-tcatgatctgaagaatctgtgtacc 
N-Bak Forward 5´-tgcaagcttccaccatggcatctggacaagga 
 Reverse 5´-ttcctcgagtcaggatccggaggcgatcttggtgaa 
N-Bak∆TM Forward 5´-tgcaagcttccaccatggcatctggacaagga 
 Reverse 5´-tgcggatcctcatcttaaataggctgtgca 
N-BakL78E Forward 5'-cttgctctcatcggagccgatattaaccggcgc 
 Reverse 5'-gcgccggttaatatcggctccgatgagagcaag 
N-BakD81A Forward 5'-cttgctctcatcggagccgatattaaccggcgc 
 Reverse 5'-gcgccggttaatatcggctccgatgagagcaag 
Bak, BakL78E or D81A Forward the same as N-Bak, N-BakL78E or D81A 
 Reverse the same as N-Bak, N-BakL78E or D81A 
Bak1-114 Forward 5´-tgcaagcttccaccatggcatctggacaagga 
 Reverse 5´-ttcctcgagtcaggatccggaggcgatcttggtgaa 
Bak1-90 Forward 5´-ttcaagcttccaccatggcatctggacaagga 
 Reverse 5´-tcgctgcagtcacgaattctggaactctgtgtc 
N-Bak115-151 Forward 5´-ttcggatccaccatgaggccagcagcaacatgc 
 Reverse 5´-tcgtctagactcgagtcaaaccacgctggtaga 
N-Bak126-151 Forward 5´-ttcggatccaccatgagagtggcatcagctgg 
 Reverse 5´-tcgtctagactcgagtcaaaccacgctggtaga 
Bax1-98 Forward 5´-tataagcttccaccatggacgggtccggggagca  
 Reverse 5´-tccggatcctcagtcagctgccacccggaaga  
Blk Forward 5´-ccacatgtcggaggcgagacttat 
 Reverse 5´-tcactgaagctgcaaatacc  
primer flanking N-exon Forward 5-ttgcccaggacacagaggaggt 
 Reverse 5-gaattggcccaacagaaccacacc 
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3.3. RNase protection assay 
 
The RNase protection assay was performed as described. Full-
length N-Bak cDNA was used to generate 32P-labeled antisense 
RNA probe. For a positive control, the mouse β-actin riboprobe 
(Ambion Inc., Austin, TX) was used. 
 
3.4. Transfection and microinjection 
 
COS-7 or Neuro2a cells at 50-80% confluence were transfected 
with the indicated expression plasmids or with the mock vector 
using Fugene transfection reagent (Roche Molecular 
Biochemicals) or Lipofectamine 2000 (Life Technologies, Inc.) 
according manufacture’s instruction. The plasmid encoding for 
enhanced green fluorescent protein (pEGFP-C1, Clontech) was 
co-transfected to reveal transfection efficiency. For survival 
assay, Neuro2A or COS-7 cells in 96-well plates (Falcon) at 50% 
confluence were transfected with expression plasmids for 
individual proteins together with pEGFP at a ratio of 5 to 1. The 
cells were fixed after 48 hours post transfection with 4% of 
paraformaldehyde in PBS, and the EGFP fluorescence was 
measured in the individual wells by Wallac 1420 Victor multilabel 
counter (Wallac OY, Finland). To quantify the efficiency of co-
expression of the two plasmids, in preliminary experiment, we 
co-transfected COS-7 cells with the expression plasmids for red 
fluorescent protein (pERFP-C1) and pEGFP-C1 at different 
ratios, and counted microscopically the number of yellow cells 
(co-expressing both plasmids) and green cells (expressing only 
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EGFP) at 48 h after transfection. At the pEGFP-C1: pERFP-C1 
ratio of 1:5, the percentage of green cells from all fluorescent 
cells was 2.2 ± 0.4%. This ratio of plasmids was chosen for the 
assay. 
For transfection of cultured SCG neurons, nuclei of the 
SCG neurons were injected with the expression plasmids of 
interest (50 ng/µl), together with 10 ng/µl of EGFP encoding 
plasmid. To detect activated caspase-3, pCaspase-3-Sensor 
Vector (30 ng/µl), containing the caspase-3 cleavage site 
(Bossy-Wetzel et al., 1998) before the yellow fluorescent protein 
reporter, was included. Neurons were grown further with NGF or 
in NGF-free medium with function-blocking anti-NGF antibodies 
(Roche Molecular Biochemicals). Initial neurons surviving the 
procedure were counted 3–4 h later. 30–100 neurons were 
successfully injected with each plasmid in every experiment. To 
follow all injected neurons individually, the positions of the 
injected neurons were mapped according to the grid scratched in 
the bottom of the dish. Healthy fluorescent neurons with phase-
bright cytoplasm and an intact neuritic tree were counted daily 
and expressed as a percentage of the uninjected cells. 
 
3.5. Immunoblotting and immunocytochemistry 
 
Mouse tissues or cultured cells were homogenized and lysed on 
ice for 30 min in either 1% SDS buffer (10 mM KCl, 2 mM EDTA, 
1% SDS in PBS) or in the lysis buffer containing 20 mM Tris-
HCl, 150 mM NaCl 2 mM EDTA, 1% Triton X-100, 1% NP-40. All 
the lysis buffers were supplemented with PMSF (10 µg/ml) and 
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standard protease inhibitors (Roche Molecular Biochemicals). 
The protein lysates were analyzed by SDS-PAGE followed by 
immunoblotting with the indicated antibodies.  
For immunostaining, the cells on glass coverslip were 
fixed with 4% paraformaldehyde in PBS for 15 min at room 
temperature, permeabilized with 0.3% Triton X-100, and stained 
with the indicated antibodies. The cells were examined by 
epifluorescence or confocal microscopy. The images were 
processed with Adobe Photoshop software. 
 
3.6. Electron microscopic analysis 
 
Neurons were cultured on CellLocate coverslips (Eppendorf) for 
4–5 days and microinjected with plasmid encoding for N-Bak. 
Two days later phase-contrast and fluorescence 
microphotographs were taken of the injected cultures. The 
neurons were then fixed with 2% glutaraldehyde for 30 min at 
room temperature, postfixed with 1% reduced osmium tetraoxide 
for 1 hr, and processed for Epon embedding, as described. 
Injected fluorescent neurons were localized according to the 
coordinates of CellLocate coverslips using microphotographs 
taken before fixation. Sections were cut from the injected 
neurons parallel to the coverslip, picked up on single-slot copper 
grids, poststained with uranyl acetate and lead citrate, and 
examined using a Jeol JEM-1200EX II transmission electron 
microscope at 80 kV. 
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3.7. Statistical analysis 
 
Statistical significance of the data was analyzed by one-way 
analysis of variance, followed by Tuckey’s post hoc test at a 
significance level of 0.05 or by two-tailed Student´s t test with 
two-sample unequal variance. Null hypothesis was rejected at 
P<0.05. 
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4. RESULTS 
 
4.1. N-Bak, a novel isoform of Bak, is a BH3-only protein (I) 
 
When analyzing the nucleotide sequence of Bak from mouse 
brain, we noticed a 20-bp sequence 
(GCCAGCAGCAACATGCACAG) missing in the mouse Bak 
sequence derived from the epithelial 3T3 cells. This sequence 
was inserted exactly at the junction of exons 4 and 5 of the 
mouse Bak gene, suggesting that the 20-bp insert is a hitherto 
undescribed exon. Indeed, the 20-bp sequence was found in the 
intronic sequence between exon 4 and 5 being flanked by 
canonical intron-exon junction sequences corresponding to the 
GT-AG rule. We designated this exon as exon N for “neuron-
specific” exon and the transcript including this exon as N-Bak.  
Usage of exon N leads to reading frameshift with a premature 
stop codon. The predicted N-Bak protein contains 150 amino 
acids, with a molecular mass of 16.4 kDa, whereas the 
previously described Bak isoform has 208 amino acids with a 
molecular mass of 23.3 kDa. N-Bak lacks the BH1 and BH2 
domains but the BH3 domain is preserved. The novel C-terminal 
amino acid stretch of N-Bak has no homology to any of the 
known proteins. 24 C-terminal residues of this novel sequence 
(VASAGAAWWLSWALATVWPCTSTS) can form a trans-
membrane α-helix. Thus, usage of exon N converts the 
multidomain Bak protein into a BH3-only protein with a novel 
putative transmembrane domain that.  
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A similar 20-bp sequence 
(GCCAGCAGCAACACCCACAG) was found in Bak cDNA 
clones from human brain with two nucleotide differences from 
mouse exon N. This human sequence is inserted at the position 
identical to that in mouse Bak cDNA, leading to the same 
changes in amino acid sequence as in mouse N-Bak. 
 
4.2. N-Bak is neuron-specific and its expression is 
correlated to neurogenesis (I, IV) 
 
RT-PCR analysis showed that Bak is expressed in all studied 
mouse and rat tissues, whereas N-Bak was expressed 
exclusively in the nervous tissue. Identical results were obtained 
when RNAs from human tissues were analyzed by RT-PCR. 
RNase protection assay also revealed expression of Bak 
transcripts in all adult mouse tissues analyzed, whereas N-Bak 
was detected only in brain. Both transcripts of Bak were detected 
in cultured cells of rat cerebral cortex and hippocampus that 
contained neurons as well as non-neuronal cells. In contrast, the 
non-neuronal cells from rat cerebral cortical culture and the rat 
sciatic nerve expressed only Bak, suggesting that N-Bak may be 
expressed only in the neurons. We then directly demonstrated 
that the neurons from at least SCG and hippocampus expressed 
only N-Bak mRNA but not Bak mRNA. Conversely, only Bak 
mRNA (but not N-Bak mRNA) was expressed in non-neuronal 
cells. Although we did not analyze other neuronal populations, it 
is probable that the Bak transcript in brain tissues may be of glial 
origin. Thus, expression of N-Bak is strictly neural tissue-specific 
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and, at least in SCG and hippocampus, strictly neuron-specific, 
whereas Bak is expressed almost ubiquitously, but is absent in 
the neurons. Exon N, as well as neuron-specific expression of N-
Bak, is conserved in the mouse, rat, and human species.  
To study the developmental expression of N-Bak during 
early neurogenesis, we isolated total RNA from the neural tubes 
and brains of embryonic or newborn mice. RT-PCR was 
performed. Bak was highly expressed before the neurogenesis 
and its expression level decreased dramatically with the 
neurogenesis. In contrast, N-Bak was absent before 
neurogenesis and became detectable at E10, well correlated 
with the onset of neurogenesis. N-Bak expression level as well 
as the ratio of N-Bak versus Bak increase dramatically with the 
development of nervous system and peaked around birth. We 
thus hypothesize that during neurogenesis, Bak may be spliced 
to N-Bak in newly generated postmitotic neurons or perhaps in 
the cells that have just acquired neuronal identity. Interestingly 
we found that Bak and N-Bak are co-expressed in PC12 and 
neuroblastoma cells, two cell lines of neural origin and with the 
potential to acquire neuronal phenotypes. This finding 
additionally suggests that alternative splicing of Bak to N-Bak 
could take place during neuronal specification and/or 
differentiation, and complete in terminally differentiated neurons.  
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4.3. N-Bak and N-Bak-like mutants are proapoptotic in non-
neuronal cells (I, II) 
 
To study the functionality of N-Bak and the structural 
requirements for its function, we generated C-terminal truncated 
mutants as well as BH3 domain mutants of Bak and N-Bak 
(Table 2)  
N-Bak, Bak and Bax functioned similarly in non-neuronal 
cells. Ectopically expressed N-Bak is a potent apoptosis-
promoting protein in non-neuronal cells. Only 10.6 ± 1.3% of 
Bak-injected and 12.4 ± 0.5% of N-Bak-injected primary non-
neuronal cells from P1 mouse SCG remained alive 24 hr after 
injection as compared to 90.7 ± 1.2% of survival of the vector-
injected control cells. Nuclei of the EGFP-N-Bak-transfected 
HeLa cells exhibited apoptotic features being fragmented and 
containing condensed chromatin, as shown by staining with 4,6-
diamidino-2-phenylindole.  
When overexpressed in COS-7 cells or neuroblastoma 
Neuro2A, N-Bak, but also Bak and Bax, efficiently killed COS-7 
cells. Successive C-terminal truncations of N-Bak up to residue 
90 did not diminish its killing activity showing that the sequences 
downstream of BH3 domain are not necessary for the pro-
apoptotic properties of N-Bak (and Bak). N-Bak kills the cells 
despite the absence of transmembrane domain or all unique C-
terminal amino acids, whereas the C-terminal fragments 
downstream of BH3 domain (N-Bak 115-151 and N-Bak 126-
151) had no killing activity on their own. Mutation L76E in the 
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BH3 domain eliminated cytotoxic function of N-Bak and Bak in 
COS-7 and Neuro2A cells, whereas mutation D81A did not.  
C-terminally truncated Bax had slightly but statistically 
insignificantly reduced death-promoting activity, as compared to 
full-length Bax or N-Bak. Overexpression of BH3-only protein Blk 
was highly toxic for COS-7 cells, and this toxicity was not 
reduced when the transmembrane domain of Blk was deleted.  
 
 
4.4. N-Bak and N-Bak-like mutants are anti-apoptotic in SCG 
neurons (I, II) 
 
Overexpression of Bak rapidly killed cultured SCG 
neurons even in the presence of NGF. In contrast, in the 
presence of NGF, 93.7 ± 2.4% of N-Bak-expressing neurons 
remained healthy, which does not differ significantly from vector-
injected or uninjected neurons. When deprived of NGF, 19.4 ± 
6.7% of the uninjected neurons and 17.8 ± 8.6% of the vector-
injected neurons remained alive 72 h after injection. In contrast, 
78.0 ± 2.2% of the N-Bak-expressing neurons survived NGF 
removal. Thus, in neurons, alternative splicing converts pro-
apoptotic Bak into anti-apoptotic N-Bak. Deletion of 
transmembrane domain or all N-Bak-specific sequences (Bak 1-
114) or eleven juxtamembrane N-Bak-specific amino acids (N-
Bak∆115-124) slightly but not statistically significantly reduced 
its protective activity. Also, C-terminal fragments of N-Bak (N-
Bak 115-151 and N-Bak 94-151) had no survival-promoting 
activities. Thus, N-Bak-specific residues, including 
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transmembrane domain, are not critical anti-apoptotic 
determinants of N-Bak. But the C-terminal deletion up to amino 
acid residue 90 almost completely abolished survival-promoting 
effect of N-Bak, suggesting that the context downstream of BH3 
domain seems to be still required for neuroprotective activity of 
N-Bak. 
Both amino acid changes in the BH3 domain affected the 
killing activity of Bak similarly in non-neuronal cells and neurons, 
indicating that the killing property of Bak in neurons and non-
neuronal cells is dependent on its BH3 domain. Both BH3 
mutations only slightly reduced the survival-promoting properties 
of N-Bak in SCG neurons. However, N-Bak is completely 
inactivated by mutations in BH3 domain (Bak 1-114-L76E and 
Bak 1-114-D81A) combined with C-terminal deletion. Together, 
these results suggest that although neither C-terminus nor the 
BH3 domain seemed to be the single determinant, a functional 
N-Bak module with BH3 domain and its surrounding context is 
required for neuroprotective activity of N-Bak.  
C-terminally truncated Bax (Bax 1-98), a structural 
analogue of N-Bak, behaved very similarly to N-Bak. It killed 
non-neuronal cells almost as efficiently as full-length Bax but 
rescued almost all NGF-deprived neurons. Moreover, like N-Bak, 
truncated Bax did not kill the neurons maintained with NGF. Blk, 
a BH3-only protein, was highly toxic to both non-neuronal cells 
and neurons. Surprisingly, deletion of transmembrane domain of 
Blk also converts it into survival-promoting protein in neurons, 
although the same protein efficiently killed non-neuronal cells. 
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Table 2. Constructs used in this study 
Construct Encoded protein In non-neuronal cells In SCG neurons 
Bak full-length Bak Pro-apoptotic Pro-apoptotic 
BakL76E Bak BH3 mutant, Leu76 to Glu Inactive Inactive 
BakD81A Bak BH3 mutant, Asp81 to Ala Pro-apoptotic Pro-apoptotic 
Bak1-114 Bak N-terminal 1-114 Pro-apoptotic Anti-apoptotic 
Bak1-90 Bak N-terminal 1-90 Pro-apoptotic Inactive 
N-Bak full length N-Bak Pro-apoptotic Anti-apoptotic 
N-BakL76E N-Bak BH3 mutant, Leu76 to Glu Inactive Anti-apoptotic 
N-BakD81A N-Bak BH3 mutant, Asp81 to Ala Pro-apoptotic Anti-apoptotic 
N-Bak∆TM N-Bak, TM deletion Pro-apoptotic Anti-apoptotic 
N-Bakd115-125 N-Bak, deletion of 115-125 Pro-apoptotic Anti-apoptotic 
N-Bak115-151 C-terminus (115-151) of N-Bak Inactive Inactive 
N-Bak126-151 TM domain of N-Bak Inactive Inactive 
Bax Full-length Bax Pro-apoptotic Pro-apoptotic 
Bax1-98 Bax N-terminal 1-98 Pro-apoptotic Anti-apoptotic 
Blk Full-length Blk Pro-apoptotic Pro-apoptotic 
Blk∆TM Blk, TM deletion Pro-apoptotic Anti-apoptotic 
 
 
4.5. N-Bak protects SCG neurons downstream of 
cytochrome c release by interfering with activation of 
caspases (IV) 
 
When overexpressed in cultured SCG neurons, N-Bak and 
Bax1-98 did not prevent the release of cytochrome c from the 
mitochondria to the cytosol suggesting that these proteins 
prevent sympathetic neuronal death downstream of cytochrome 
c release. Surprisingly, N-Bak even potently induced cytochrome 
c release but still prevented the death of the neurons. Further 
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study showing the lack of cleavage of DEVD-fluorophore 
suggested that the activation of (at least) caspase-3 might be 
blocked in these neurons. Thus, N-Bak and Bax1-98 may protect 
neurons by interfering with caspase activation. This result was 
further indirectly supported by electron microscopic analysis of 
N-Bak overexpressing sympathetic neurons. Compared to NGF-
deprived control neurons, in which evenly distributed 
mitochondria remained largely normal with tubular-like shapes 
and discernable cristae structure, the mitochondria from NGF-
deprived, N-Bak overexpressing neurons (in 14 neurons, n=24) 
were clustered, appeared larger and contained fewer cristae that 
were often of vesicular shape, an indication of mitochondrial 
rearrangement. In most of these mitochondria, only one 
membrane was visible (probably the inner membrane). Similar 
mitochondrial changes were observed in NGF-maintained, N-
Bak overexpressing neurons, indicating that N-Bak itself actively 
induced mitochondrial changes and this activity is not related to 
the apoptotic stimulus (NGF deprivation). Thus the release of 
cytochrome c in N-Bak overexpressing neurons could be 
attributed to the disruption of outer mitochondrial membrane. In 
contrast to NGF-deprived control neurons, in which chromatin 
condensation and nuclear fragmentation were the predominant 
features (in 10 neurons, n=22), the nuclei of the N-Bak 
overexpressing neurons (in 11 neurons, n=12) remained mostly 
intact. As the activation of caspase-3 is absolutely required for 
the formation of apoptotic chromatin, we conclude that caspase-
3 may not be activated in the N-Bak-overexpressing neurons, 
despite of cytosolic localization of cytochrome c.  
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4.6. Endogeneous Bak mRNA and protein are not expressed 
and endogeneous N-Bak protein is not detected in SCG 
neurons (I, IV) 
 
Although mRNA of N-Bak is highly expressed in neurons, we 
failed to detect N-Bak protein by Western blotting in whole SCG 
or sympathetic neuronal cultures with or without NGF, and in 
murine brain samples from different development stages. The 
anti-Bak antibodies used in the study bind to N-terminal epitope 
common to both Bak and N-Bak. These antibodies always 
detected Bak but never N-Bak in the brain samples or neuronal 
cultures, even when the mRNA levels of N-Bak were much 
higher than those of Bak. These antibodies also detected 
ectopically expressed N-Bak in transiently transfected Bcl-xL-
protected COS-7 cells or in the sympathetic neurons 
microinjected with N-Bak expression plasmid, but never the 
endogeneous N-Bak. We therefore hypothesize that N-Bak 
protein is not constitutively translated but the translation may be 
induced under certain circumstances. In an attempt to find these 
circumstances, we treated cultured cortical neurons, 
hippocampal neurons and cerebellar granule neurons with 
etoposide, staurosporine, cycloheximide or hypoxia. Under all 
these conditions, we did not detect N-Bak protein. The 
conditions putatively inducing N-Bak mRNA translation remain to 
be found.  
In all samples we did detect Bak protein, raising the 
question whether Bak protein is expressed in neurons or in the 
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glial cells. To answer this question, we prepared essentially glia-
free SCG cultures by extensive pre-plating and anti-mitotic drug 
cytosine arabinoside (AraC). Removing of the glial cells from the 
cultures also removed Bak-specific band, as revealed by 
Western blotting, showing that Bak is expressed only in the glial 
cells but not in the neurons of the SCG cultures. We were not, 
however, able to apply the same approach to the cultures of 
central neurons, as the glial cells in these cultures were more 
resistant to AraC treatment, whereas the neurons did not tolerate 
well this drug.  
 
4.7. Two alternative splice variants of Bad are functionally 
indistinguishable (III) 
 
Bad is a BH3-only member of Bcl-2 family that is essential in 
regulating apoptosis of several nonneuronal cells, in particular 
interleukin-3-dependent pre-B-lymphocytes. In healthy cells, Bad 
is inactivated by phosphorylation and binding to a scaffold 
protein 14-3-3. After apoptotic stimulus (e.g. interleukin-3 
deprivation), Bad becames dephosphorylated, dessociated from 
14-3-3 and moves to mitochondria, where it binds and 
inactivates anti-apoptotic Bcl-2 and Bcl-xL (Zha et al., 1996; 
Datta et al., 1997). Bad is expressed in the nervous system 
(Shimohama et al., 1998) including the SCG neurons (our 
unpublished data). Overexpressed Bad induced death of 
cerebellar granule neurons (Datta et al., 1997). However, the 
role of Bad for SCG neurons remains unclear, as Bad-deficient 
SCG neurons release cytochrome c to the cytosol and die 
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apoptotically by NGF deprivation indistinguishably from the wild-
type neurons (Putcha et al., 2002).  
 In collaboration with prof. Dan Lindholm, we performed 
functional characterization of Bad-β, a new splice isoform of Bad. 
Bad-β is created differently than N-Bak: usage of a downstream 
splice acceptor site in the last exon, resulting in loss of the stop 
codon and usage of the 3´-untranslated region of Bad-α (the 
previously described isoform of Bad). Thus, Bad-α and Bad-β 
proteins differ in the C-terminal region only. RNase protection 
assay showed that both Bad isoforms are equally expressed in 
several neural and nonneural tissues. We found that 
overexpression of either Bad isoform in NGF-maintained SCG 
neurons killed significant fraction of the neurons. However, 
overexpression of Bad-α or Bad-β in apoptotic NGF-deprived 
neurons did not accelerate their death, differently from 
overexpressed Bax, Bak or Blk (I, II), whereas in non-neuronal 
cells, overexpressed Bad-α has been shown to be highly toxic. 
Thus, these BH3-only proteins also behaved differently in the 
neurons than in non-neuronal cells. However, we did not find any 
difference in the expression and function of Bad-α and Bad-β. 
The biological function of splicing of Bad mRNA remains unclear.  
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5. DISCUSSION  
 
Tissue or cell type-specific alternative splicing is important in 
increasing the diversity of the proteins controlling multiple 
cellular functions, including programmed cell death (Jiang and 
Wu, 1999; Lykke-Andersen, 2001; Lewis et al., 2003). A number 
of genes involved in the programmed cell death are spliced into 
functionally different or even antagonistic isoforms. Alternative 
splicing may influence the mRNA stability, translation, tissue or 
cell specificity as well as subcellular distribution, thereby 
providing a fine-tuning modulation of cell death program.  
We discovered an alternatively spliced BH3-only isoform 
for the pro-apoptotic BH1-3 domain Bcl-2 family protein Bak. 
Similarly, BH3-only versions have been described for Bcl-x 
(Boise et al., 1993) and Mcl-1 (Bae et al., 2000; Bingle et al., 
2000) that are, however, anti-apoptotic Bcl-2 family members. 
This is first description of BH3-only isoform for a pro-apototic 
protein. Most of the other known splice variants of the Bcl-2 
family proteins have changes in the C-terminal regions of the 
proteins or the regions encoding one or more BH domains are 
missing. The functionality of these splice variants remains mainly 
unchanged (Yang et al., 1997; Yang et al., 1997; Fang et al., 
1994; Oltvai et al., 1993;Schmitt et al., 2000; Zhou et al., 1998; 
Negrini et al., 1987; Shi et al., 1999; Apte et al., 1995; Hsu and 
Hsueh, 1998; O'Connor et al., 1998; Bouillet et al., 2001; Marani 
et al., 2002). Also, no differences in the expression or function of 
the two alternatively spliced isoforms of Bad, having differences 
in the C-terminal region, was found (III).  
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We found that the transcripts of Bak isoforms are strictly 
expressed in different tissues: N-Bak in the neural tissues and 
Bak in nonneural tissues. At least in the cultures of SCG and 
hippocampus, N-Bak is expressed only in the neurons and Bak 
is expressed only in the non-neuronal cells. Thus, in these 
neurons, alternative splicing completely replaces Bak mRNA 
with N-Bak mRNA, whereas this event does not occur in the glial 
cells. We also found that N-Bak mRNA appears in the embryonic 
neural tube concomitantly with the beginning of neurogenesis. 
We therefore hypothesize that neurons may not tolerate Bak and 
must remove it by alternative splicing. Bak may be necessary in 
keeping a proper pool size of the proliferative neural stem cell or 
neural progenitors. But in post-mitotic neurons and/or 
differentiating neuronal cells, the death program is re-written and 
Bak is removed. In accordance with that, accumulation of excess 
neural stem cells and progenitors in the central nervous system 
was found in the Bax-Bak double-deficient mice (Wei et al., 
2001;Lindsten et al., 2000) suggesting a role of Bak in the early 
development of nervous system, perhaps before or during 
neurogenesis. 
Although we do not have yet direct evidences, we 
hypothesize that Bak is missing in other neurons as well. 
Expression of Bak in the neurons has not been directly 
demonstrated in the literature. Bak immunoreactivity in the 
restricted regions of mouse brain has been demonstrated 
(Krajewska et al., 2002). However, it was not possible to 
distinguish from the tissue sections which cells (neurons or glial 
cells) express Bak. It was also shown recently, that Bak-deficient 
 76 
mice were more susceptible to Sindbis virus infection-induced 
toxicity, and this toxicity was reduced by overexpression of 
exogenous Bak (Fannjiang et al., 2003). As the Sindbis virus 
vectors used in this study infected mainly the neurons, it was 
concluded that lack of endogenous Bak in the neurons make 
them more vulnerable to Sindbis virus. However, no direct 
evidences for neuronal expression of Bak was presented in this 
study, whereas the apoptotic pathways are often changed in the 
mice deficient of apoptosis-regulating proteins (Troy et al., 2001; 
Harlin et al., 2001; Oppenheim et al., 2001; Zaidi et al., 2001). 
More studies are required to ascertain whether Bak is expressed 
in the CNS neurons or not. 
We found that also N-Bak protein was not expressed in 
the neurons that, however, expressed N-Bak mRNA. Although 
further studies are needed, the most probable explanation is that 
N-Bak mRNA is not normally translated. Increasing evidences 
suggest that a quality-control mechanism (nonsense-mediated 
mRNA decay) removes mRNAs that contain premature 
(nonsense) stop codon and one exon-exon junction more than 
50 nucleotides downstream of it (Lykke-Andersen, 2001; Lewis 
et al., 2003). These features are present in the N-Bak mRNA. 
Alternatively, our preliminary results showed that 5’ untranslated 
regions of Bak and N-Bak are identical and EGFP-reporter 
construct with EGFP fused to 5’ untranslated region of N-Bak 
revealed only weak fluorescence in the microinjected SCG 
neurons. Thus, the translation of N-Bak mRNA may also be 
controlled by its untranslated regions. We are currently testing 
these hypotheses. It is possible that N-Bak protein expression 
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may be induced in certain circumstances. Our attempts to find 
these circumstances (treatment with etoposide, staurosporine, 
cycloheximide, hypoxia) have so far failed. Thus, the conditions 
of N-Bak protein expression remain unclear. 
If overexpressed in the neurons, however, N-Bak is 
involved in the apoptotic pathways that differ from the “classical” 
ones described for the immune, hematopoietic or fibroblastic 
cells. Although all BH3-only proteins are shown to be pro-
apoptotic (Huang and Strasser, 2000), N-Bak does not trigger 
death of the neurons. Instead, it even retards the apoptotic 
program triggered by NGF removal. BH3-only proteins trigger 
the apoptosis via their BH3-domain that binds to other Bcl-2 
family proteins (Bouillet and Strasser, 2002). Neuronal anti-
apoptotic activity of N-Bak, however, was not mediated by its 
BH3 domain (although the killing of nonneuronal cells was). Our 
results suggest that, instead, the whole N-Bak protein or “N-Bak-
like module” is involved in its neuronal anti-apoptotic activity. 
Such non-BH3-mediated activities have not been described for 
BH3-only proteins earlier. We surprisingly found that N-Bak 
actively changed the ultrastructure of neuronal mitochondria, 
causing the disappearance of the outer membrane and 
rearrangement of the cristae. The mechanism of these changes 
remains unknown, but it differs from the processes of 
cytochrome c release in the “classical” intrinsic apoptotic 
pathway, where specific pores or channels are generated to the 
mitochondrial outer membrane, whereas the membrane itself 
remains relatively intact (Parone et al., 2002; Roucou et al., 
2001; Martinou and Green, 2001). As expected from the 
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mitochondrial changes, cytochrome c was cytosolic in most of 
the N-Bak-expressing neurons. In non-neuronal cells, such 
events would inevitably trigger caspase activation and rapid 
death (Budihardjo et al., 1999). In neurons, however, the 
caspases seem to be blocked, so that even the death triggered 
by another stimulus (NGF removal) is blocked or retarded. It is 
shown by others (Deshmukh et al., 2002), that microinjection of 
cytochrome c protein into the cytosol of the SCG neurons does 
not trigger their death (whereas it rapidly kills nonneuronal cells). 
Injected cytochrome c induces, however, death of the neurons 
that were deprived of NGF and have released Smac/DIABLO 
from the mitochondria to the cytosol. It has been suggested 
(Deshmukh et al., 2002) that the caspases in the SCG neurons 
(but not in non-neuronal cells) are strongly inhibited by IAP 
proteins and cannot be activated without Smac/DIABLO. These 
results are in accordance with our data. We hypothesize that 
Smac/DIABLO, which is critically required together with 
cytochrome c to activate caspases in the SCG neurons 
(Deshmukh et al., 2002), is not available in N-Bak-
overexpressing neurons, and therefore cytochrome c cannot 
activate the caspases. The localization of Smac/DIABLO in the 
N-Bak-expressing neurons remains to be studied. 
Our studies further confirm that apoptotic pathways in the 
neurons are remarkably different from those described for some 
non-neuronal cells (Putcha et al., 2002; Deshmukh et al., 2002; 
Deshmukh et al., 2000; Putcha et al., 1999; Deshmukh and 
Johnson, Jr., 1998; Martinou et al., 1999; Xue et al., 1999). 
Although the key events (translocation of Bax to the 
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mitochondria, release of cytochrome to the cytosol and activation 
of caspases) are the same in different cells, several regulatory 
events (the role of Bak, control of caspase activation) are not. 
The main goal of our studies is to contribute to the generation of 
neuron-specific model of apoptosis.  
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6. CONCLUSIONS 
 
• In the (at least sympathetic and hippocampal) neurons but 
not in non-neuronal cells, alternative splicing replaces the 
mRNA of BH1-3 Bak with the mRNA of BH3-only N-Bak. 
 
• Alternative neuron-specific splicing of Bak mRNA begins 
concomitantly with the beginning of neurogenesis. 
 
• Overexpressed N-Bak is pro-apoptotic in the non-
neuronal cells, but anti-apoptotic in the sympathetic 
neurons. 
 
• In the (at least sympathetic) neurons, overexpressed N-
Bak retards apoptotic death by novel BH3-independent 
mechanism including changes in the mitochondrial 
ultrastructure and blockage of caspase activation.  
 
• Endogeneous N-Bak protein remains undetectable 
suggesting that N-Bak mRNA is not constitutively 
translated in the neurons.  
 
• Expression and functional properties of two alternatively 
spliced isoforms of Bad are indistinguishable. 
 
• Regulation of apoptosis is considerably different in 
neurons and non-neuronal cells.  
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